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1. Background
Traditional transplantation surgeries using autologous and allogenic grafts have several limitations, 
such as lack of an appropriate donor source, risk of disease transmission and foreign body rejection1. 
Tissue engineering could potentially circumvent these problems. It combines materials science, 
engineering and biology, and aims to develop substitutes that can restore and/or maintain 
normal tissue and organ function2. Non-invasive monitoring is essential to optimize the different 
processes involved in tissue engineering. Although many imaging modalities have been applied for 
this purpose, non-invasive assessments remain cumbersome. Firstly, many of them have intrinsic 
limitations: such as limited penetration depth, introducing ionizing radiation, and the incapability 
of offering relevant information for certain tissues3. Secondly, the standard methods are often 
not suitable for the intended assessment. For example, there is a lack of specific radiotracers for 
engineered tissue in nuclear imaging. Recently, Magnetic resonance imaging (MRI), is emerging as 
an acctractive alternative since its use can overcome some of these limitations and can monitor the 
entire span of the different steps in the tissue engineering process.
2. PrinciPals of tissue engineering and iMaging  
in tissue engineering
2.1. tissue engineering
The ultimate goal of tissue engineering is to develop complex tissues or organs such as heart, 
muscle, kidney, liver, and lung, but their realization is still a distant milestone. Current research 
in tissue engineering seeks to partly restore, replace or regenerate tissue functions. Significant 
progress has been made in repairing bones, tendons, cartilages, ligaments, bladder, urethral 
and dentinal-pulpal structures 4,5,6,7,8,9.
These approaches often require the use of cells, which are able to proliferate and 
differentiate10. Based on their origin, they fall into three categories: autologous cells from the 
patient, allogeneic cells from another human donor, and xenogeneic cells from other species. 
Following the successful collection of cells, they are expanded in cell culture and then seeded 
into an artificial scaffold together with appropriate modulating molecules (Fig. 1). 
The materials to fabricate three dimensional (3D) biocompatible scaffolds are mainly synthetic 
polymers (for example, polymers such as poly- glycolic acid or hydrogels) and natural derived 
substances (for example, agarose, alginate, or collagen)11. The performances of these materials 
after implantation are critical in achieving a successful recovery. Firstly, these scaffolds have to 
facilitate the delivery of cells. Secondly, they must support cell proliferation, differentiation and 
diffusion of nutrients, and therefore need to be porous. In addition, they should have sufficient 
mechanical strength to support the surrounding tissues, from the time of transplantation till 
the end of the healing process. Biomolecules are added to improve regeneration, including 
angiogenic factors, growth factors and differentiation factors. After implantation, combinations 
of these three components (cells, scaffolds and biomolecules) are supposed to generate 
functional vascular networks, which deliver nutrients and oxygen to the engineered tissue.
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2.2. imaging in tissue engineering
During the regeneration process, the structure, composition and strength of engineered tissue 
implants and surrounding tissues needs to be regularly assessed, to ensure optimal growth 
and also to enable further optimization. Histology and immunohistochemical techniques have 
been widely used for this purpose. However, these techniques are invasive and destructive. 
Moreover, they are incapable to provide quantitative information such as volume assessment 
and cell density, which are critical in the evaluations. Therefore, many non-invasive imaging 
techniques such as optical imaging, ultrasound imaging, X-ray imaging and nuclear imaging 
have been explored to examine the structure and functions of the implants and tissue responses 
after implantation12. 
Optical imaging, which measures the light transmitted through or reflected by the samples, 
is a widely available technique. Cells in polymeric scaffolds and vascular structure can be 
labeled and tracked in small animals13. The major disadvantages of optical imaging are the lack 
of penetration depth and the small regions that are covered by the light source. One other 
imaging modality is ultrasound imaging, which measures the returning signals from acoustic 
waves. It has been applied to evaluate the formation of engineered cartilage and the degradation 
of hydrogel14,15,16. However, it has limited penetration depth and low spatial resolution. A third 
imaging modality, X-ray based imaging measures the absorption, reflection and /or scattering 
of X-ray and has been extensively used in the in vivo monitoring and study of engineered bone 
tissues17,18,19. However, its application in tissue engineering is limited, due to its low contrast 
for soft tissue. Besides this, the ionizing radiation could introduce potential damage to the 
samples, animals and patients, especially in a longitudinal study. Nuclear imaging based on the 
detection of gamma rays, has also been used to obtain functional information from engineered 
tissues and for cell tracking20,21. However, it suffers from low spatial resolution, and it doesn’t 
offer anatomical information and therefore it needs to be applied together with other imaging 
Figure 1. A flow diagram of bone tissue engineering. After isolation from bone marrow, mesenchymal stem cells 
(MSCs) are allowed to proliferate  in vitro. The cells are then seeded into the biocompatible scaffold along with 
growth and differentiation factors. The cells continue to grow and differentiate in an incubator or bioreactor. Upon 
maturity, the engineered tissue is transplanted into the animal or patient. (Reprinted and adapted from Journal of 
Bioscience and Bioengineering, Volume 106, Issue 6. Huihui Xu, Shadi F. Othman, Richard L. Magin. “Monitoring 
tissue engineering using magnetic resonance imaging”, Pages 515–527, 2008, with permission from Elsevier).
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modalities. Most importantly, there is a lack of specific radiotracers for engineered tissues that 
are needed to distinguish implanted, newly formed and host tissue. 
Therefore, there is a need for a powerful non-invasive tool that can overcome some of 
these limitations, i.e. imaging with high spatial resolution of both soft and hard tissue, and 
without a limition of penetration depth. Magnetic resonance imaging (MRI) is such a tool and 
therefore starts to play an increasing role in monitoring engineered tissue. 
3. PrinciPles of Mri
3.1. Basic physics
Nuclei in atoms are spinning around their axis. They act as tiny magnetic dipoles if they contain 
one or more unpaired protons (odd charge) or neutrons (odd mass). The magnetic dipole 
moment of these spins is represented by a vector (Fig.2 A). Even through many such nuclei 
exist in a substance, normally there is no net magnetization (or macroscopic magnetization) 
since the direction of these vectors is randomly distributed. If a magnetic field is applied, the 
nuclear spins become oriented with respect to the main magnetic field B
0
, resulting in a net 
magnetization (Fig. 2 B). Spins precess about the axis of the main field B
0
. The frequency of this 
precession is given by the Larmor equation: ν = γ B
0, 
which is the principle equation behind 
all magnetic resonance imaging. It states that the resonance frequency (Larmor frequency): 
ν of a spin is proportional to the magnetic field B
0
; γ is the gyromagnetic ratio, which is a 
specific constant for a nucleus. The MR signals can be generated from the proton spins in water 
molecules or from other nuclei, such as 13C, 19F, 31P, 23Na.
The net magnetization vector lies along the direction of the applied magnetic field B
0
; and 
is called the equilibrium magnetization M
0
. By applying a temporary electro-magnetic field 
(oscillating with the same frequency as the precessing spins), also called a radiofrequency (RF) 
Figure 2. Scheme of a spin system before (A) and after (B) being placed in a main field B
0
. The magnetization of spins 
(black arrows) aligned randomly without a magnetic field. Within the magnetic field B
0
, the spins become aligned 
with the field (blue arrows) or against the field (red arrows), at a certain angle. Due to the slight excess of parallel 
spins, net magnetization M
0 
(macroscopic magnetization) is created, which has a longitudinal component (along 
the Z axis) aligned with B
0
. The direction of M
0 
maybe perturbed and then it acquires a transverse component (in 
the XY plane), which also precesses aroung B
0
.
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pulse, a simple rotation of the net magnetization vector is generated. For example, a “90° RF 
pulse” rotates the magnetization into the XY-plane (Fig. 3). Different angles of rotation can be 
achieved by applying an RF pulse with different durations or power.
After the RF pulse, the macroscopic magnetization vector precesses around B
0
. The 
re-growth of magnetization in the z-direction is termed spin-lattice relaxation. At the same 
time, the dephasing of the components of magnetization in the xy plane starts to occur, termed 
spin-spin relaxation. There are two time constants that describe these relaxation processes. First 
is the spin lattice relaxation time (T
1
), which describes how M
Z
 returns to its equilibrium value. 
The equation describing this behavior as a function of the time t is: M
z
 = M
0
 ( 1 - e-t/T1 ). T
1
 is the 
time to reduce the difference between the longitudinal magnetization (M
Z
) and its equilibrium 
value by a factor of e (Fig. 4). The other time constant describes the decay of the transverse 
magnetization, M
XY
, is called the spin-spin relaxation time (T
2
). The equation describing this 
process is: M
XY
 =M
XY0
 e-t/T2 (Fig. 4). During the relaxation processes, the net magnetization in the 
XY plane goes to zero and the longitudinal magnetization grows until Mz reaches M
0
.
3.2. Mr imaging
Besides a magnet for the main field B
0
, additional hardware components are required to obtain 
an MR image, such as field gradients. These gradients generate a variable magnetic field on top 
of the main magnetic field B
0
. By applying a linear static magnetic field gradient, the resultant 
procession of the net magnetization of spins is varied at different positions in the field (Fig. 5 A). 
The field strength differs with respect to position, and attributes a unique magnetic field to 
spins at different positions (Fig. 5 B). The symbols for a magnetic field gradient in the x, y, 
and z directions are G
x
, G
y
, and G
z
. The magnetic field at the isocenter is B
0
 and the resonant 
frequency there is ν
o.
 The frequency is proportional to the position of the spin: if a gradient in 
the magnetic field is applied in the x direction, a sample at position x will have a frequency given 
by: ν = γ ( B
0
 + x G
x
 ) = ν
0
 + γ x G
x
. In this way the position of spins can be recorded.
In MRI, a basic two-dimensional imaging procedure generally consists of three steps22. At 
first, a slice selection gradient will be turned on together with an RF pulse with a bandwidth 
Figure 3. Excitation with a 90° RF pulse, the 
magnetization is rotated into the XY-plane. During 
excitation, longitudinal magnetization decreases 
and a transverse magnetization appears.
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that only excites spins in the desired slice plane. The thickness of the slice can be varied 
by adjusting the bandwidth of this pulse  and the amplitude of the slice selection gradient. 
Secondly, a phase encoding gradient is turned on to encode spatial positions in the slice. This 
gradient is used to impart a specific phase angle to a transverse magnetization vector. This 
Figure 4.  Time curves for longitudinal, and transverse relaxation and the generated T
1
 and T
2
 contrast. Transverse 
magnetization decay is described by an exponential curve, characterized by the tissue-specific time constant 
T
2
. After time T
2
, transverse magnetization has lost 63% of its original value. The recovery of longitudinal 
magnetization also follows an exponential curve. The recovery rate is characterized by the tissue-specific time 
constant T
1
. After time T
1
, longitudinal magnetization has returned to 63% of its final value. T
1
 is always longer 
than T
2
. Different relaxations are shown for different tissues (dashed lines and solid lines). The red dashed lines 
represent the contrast between tissues, as generated by different T
1
 and T
2
 relaxation times.
Figure 5. Scheme of magnetic field gradients. A. The magnetic field gradient in the x direction Gx, can have 
different strengths. The magnetic field at the isocenter is B
0
, and will change according to the position: 
B(x)=B
0
+x*Gx. Gradients with different amplitudes can be applied (dashed and dotted lines). B. Magnet with 
hypothetical set of 9 spin systems (3x3). At different positions, the magnetic field gradient will cause that spins in 
each column to precess at different Larmor frequencies.
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angle depends on the location of the transverse magnetization vector in the direction of the 
gradient. In the chosen slice, it differentiates the ‘’rows’’. The gradient is regularly incremented, 
as many times as there are rows to be resolved. The last step is applying a frequency-encoding 
gradient during signal acquisition. This modifies the Larmor frequencies perpendicular to the 
phase encoding direction. The frequency-encoding gradient differentiates the ‘’columns’’, 
with an identical Larmor frequency.
The signal is recorded in the form of a free induction decay (FID) or in most cases as an 
echo. An important parameter is the time between the excitation RF pulse and the maximum in 
the signal, which is the echo time (TE). Classical MRI involves RF pulses and gradients that are 
repeated many times to collect all the data needed to produce an image. The time between 
the repetitions of the pulse sequence is called the repetition time (TR). Each time when the 
sequence is repeated, the magnitude of the phase encoding gradient is changed. The FIDs/
echoes are used to fill the so-called k-space, which has the unit 1/m (Fig. 6). The phase encoding 
gradient is used to position the spin system at a specific line in k-space. Application of the 
frequency-encoding gradient during signal acquisition as a function of time occurs across a 
line in k-space. The FIDs or echoes in k-space are Fourier transformed to produce the final 
MR image. The signals are first Fourier transformed in the frequency encoding direction to 
Figure 6. Scheme of k-space filling, by a classical method (Cartesian k-space) and by a back-projection method. 
Left: Position of the spin system at a specific line in k-space is determined by the phase encoding gradient. The 
frequency-encoding gradient moves the spin system across a line in k-space. The time between the repetitions 
of the sequence is also the time to fill one single line in k-space, is called the repetition time (TR). Right: Back-
projection imaging is variant of frequency encoding but with a gradient in different directions. In the back-
projection method, a one-dimensional field gradient is applied at several equally stepped angles, and signal 
is recorded for each gradient. As k-space is filled with projections, this needs to be transferred to a Cartesian 
k-space through regridding that enables further reconstruction to an image.
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extract the frequency domain information, and then in the phase encoding direction to extract 
information about the locations in the phase encoding gradient direction.
A scheme of the main hardware components to obtain an MR image is shown in Figure 7. 
The magnet produces the B
0
 field and the gradient coils produce field gradients in the X, Y and 
Z directions. Within the gradient coils, the RF coil produces another magnetic field necessary 
to excite the spins. The RF coil also records the signal from the excited spins. The computer 
controls the gradient (time, shape and amplitude), and the timing of the pulse sequence such 
as the echo time and repetition time.
3.3. Mri pulse sequences
Contrast in MRI can be obtained by making use of the specific MR properties of water in different 
tissues most prominently of the differences in relaxation times (T
1
, T
2
) of water proton spins. 
These differences arise by the specific physico-chemical (micro-) environment of the spins. 
Numerous pulse sequences have been developed to explore particular contrast in a different 
way. Spin echo (SE) and gradient echo (GRE) are two fundamental types of MR pulse sequences 
(Fig. 8). Many other MR sequences are variations of these, with different extra pulses added to 
make them sensitive to other parameters such as water perfusion, diffusion, etc.
A number of specific pulse sequences were used in this thesis, in particular 2 recently 
developed sequences that are very suitable for imaging hard tissues. The first pulse sequence 
applied in this study was the gapped Sweep imaging with Fourier Transformation (SWIFT) pulse 
sequence23. It consisted of a simple series of RF pulses, incremented gradients, and simultaneous 
data acquisition (Fig. 9). The excitation pulse is an amplitude and frequency modulated hyperbolic 
Figure 7. A block diagram of a typical MRI system with the hardware components for pulse sequence operation and 
image display. An animal, human or tissue sample (represented by a yellow square) is placed in a magnetic field (B
0
).  A 
radio frequency (RF) coil produces a small magnetic field that changes the direction of the magnetization in a manner 
prescribed by the pulse sequence. Following the RF pulses, the transverse magnetization (rotating in XY plane) induces 
a current in the radio frequency coil, which is recorded as a high frequency signal. Spatial localization is generated 
with the use of the gradient coils (Gx, Gy, Gz). The received high-frequency (MHz) signal is demodulated into a low 
frequency (kHz) signal. After this, an analog to digital converter receives analog input data and produces digital output, 
which is more compatible with the computer systems. Variation of repetition time (TR) and echo time (TE) in MR pulse 
sequences, together with proton density provide the basis for different contrast mechanism.
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secant (HS1) pulse at low peak power, which excites a large bandwidth, with a flat excitation 
profile24. The field gradient used for spatial encoding is not pulsed on and off; instead, its 
orientation is stepped in an incremental manner. The gradient waveforms are nearly continuous, 
less demanding on hardware and have a quiet operation. With virtually simultaneous excitation 
and signal acquisition, the imaging of materials consisting spins with ultra fast transverse relaxation 
rates (less than 500 µs) become possible. The second pulse sequence, which also enables ultra 
short echo time acquisition time, is the zero echo time (ZTE) sequence25,26. It comprises a hard 
pulse with a low flip angle for excitation, which covers a broad bandwidth (Fig. 9). The projection 
gradient was already on during the excitation pulse and remained constant until adjusted for 
the next repetition. After a necessary dead time delay required for changing from transmit to 
receive operation, the frequency encoded free induction decay is sampled,. The sequence is 
then repeated for the acquisition of the next projection. Images were reconstructed first using an 
algebraic reconstruction to calculate 1D radial projection data that after standard regridding are 
inversely Fourier transformed to form a 3D image (Fig. 6). 
Figure 8. Scheme of pulse sequence for spin echo (SE) and gradient echo (GRE). In SE sequences, a 90° pulse rotates 
the net magnetization vector into the transverse plane. The transverse magnetization is gradually dephased. Then 
a 180° pulse is applied at a time equal to one-half of TE to rephase the precessing nucleus spins. When the nuclei are 
again precessing in phase (at total TE), an echo is produced and recorded. In a GRE sequence, an RF pulse is applied 
that partly flips the net magnetization vector into the transverse plane. Gradients are used to dephase (negative 
gradient) and rephase (positive gradients) transverse magnetization. Compared to SE, GRE sequences are sensitive 
to magnetic field inhomogeneities secondary to magnetic susceptibility differences between tissues. 
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4. Mri aPPlied to engineered tissues
MRI has the capability of monitoring process during the entire tissue-engineering pathway: 
from the initial cell culture stage till the in vivo implantation stage, and subsequent development 
of the implants and final integration in the host tissue (Fig. 10). However, MRI is probably most 
useful in monitoring the implants in the host, as this requires a truly non-invasive approach.
Sucessful applications of MRI in monitoring engineered hard and soft tissues already 
have been demonstrated  in several studies. For engineered hard tissues, the value and 
limitations of conventional MRI in monitoring small changes in rat ectopic bone growth was 
shown27. Dynamic contrast enhanced MRI was also performed to investigate and characterize 
angiogenesis in bone formation in rabbits28. Another major application of MRI in hard tissue 
engineering is the monitoring of engineered cartilage. MRI T
2
 maps were recorded to evaluate 
the repair of a focal patellar cartilage defect in a rat29. In another study, MRI of rat spine was used 
to design a collagen (annulus fibrosus)/alginate (nucleus pulposus) total disc replacement to 
a high degree of geometric accuracy30. The in vivo performance of engineered intervertebral 
disc in a rat model was also assessed using MRI up to six months after the implantation31. 
All these studies together indicate that MRI is playing an increasingly important role in the 
evaluation of hard tissue engineering.  
MRI also has a tremendous potential in the study of soft tissue repair. It allows to monitor 
degenerative changes (early diagnosis), estimate the size, nature and location of lesions 
before surgery to evaluate the quality and success of tissue repair processes. For example, 
MRI was instrumental in the assessment of  the resorption rate of adipose tissue substitutes 
after injection of human preadipocytes within fibrin in athymic nude mice32. In vivo MRI  on 
hydrogels implanted in the trapezius muscle of rabbits33, demonstrated the effectiveness of MR 
methods in noninvasively monitoring its biocompatibility.
Figure 9. Pulse sequence scheme for ZTE and SWIFT. For SWIFT, the excitation pulse is divided into many 
segments, each having RF power on for a certain duration, followed by a delay with RF power off. Data sampling 
in SWIFT is performed at the delay after each segment (yellow bar in the pulse profile) and after the excitation 
pulse (yellow colored). For both pulse sequences, the gradients were set to the required direction and amplitude. 
They remained constant until adjusted for the next repetition.
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The use of MR contrast agents such as gadolinium diethylenetriamine pentaacetic acid 
(Gd-DTPA) and Gadomer for quantifying angiogenesis was reported in MRI of engineered 
bladder constructs34. The measurement of MR relaxation times and diffusion coefficient in 
hyaluronic acid acellular matrix implants, suggests that MRI may provide useful information on 
matrix composition and structure35. Furthermore, the measure of multi-exponential diffusion, 
T
2
* and dynamic contrast enhanced(DCE) MRI in combination, were used to access bladder 
acellular matrices prepared with and without hyaluronic acid, and matrices seeded with smooth 
muscle cells36. They are also valuable in guiding the further development of using bladder 
acellular matrices for organ regeneration and in strategies involving the use of hyaluronic acid37.
Overall, as a powerful non-invasive characterization tool, MRI has great potentials in tissue 
engineering38,39. The properties of the materials used for tissue engineering, are reflected 
in changes of many MR parameters, such as T
1
 and T
2
 relaxation times, diffusion coefficient, 
magnetic transfer, T
1ρ
, etc40,41. 
Figure 10.   Schematic description of the process of tissue engineering with the correspondence between 
MR techniques and tissue properties identified at each growth stage.( Reprinted from Journal of Bioscience 
and Bioengineering , Volume 106, Issue 6, Huihui Xu, Shadi F. Othman, Richard L. Magin. “Monitoring tissue 
engineering using magnetic resonance imaging”, Pages 515–527, 2008, with permission from Elsevier).
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5. outline of thesis
The main aim of this thesis, was to explore the possibilities of MRI to monitor specific biomaterials 
applied in tissue engineering processes, in particular collagen scaffolds and bone substitues. 
Their localization, degradation and the response of surrounding tissue to their presence were 
followed using MRI, for both engineered soft tissue and hard tissue in longitudinal studies. An 
additional aim was to develop a new approach in bone MR imaging to facilitate the assessment 
of regenerative dentistry and bone tissue engineering. 
Because of the low contrast of type I collagen scaffolds compared to host tissue, their long-term 
follow-up is troublesome. In Chapter 2, iron oxide particles’ incorporations into type I collagen 
scaffolds were tested, in order to improve their contrast, and to follow their degradation and 
tissue interactions by MRI. Scaffolds with and without iron oxide particles were implanted either 
subcutaneously or on the bladder of rats and monitored over time using MRI and by histology.
Calcium phosphate cements (CPCs) are widely used bone substitutes, which have a high 
similarity to natural bone tissue. A radiopacifier is often required for their visualization in x-ray 
imaging. However, the heavy metal incorporation and radiation makes this approach not 
appropriate for a longitudinal study. In Chapter 3, the use of ZTE MRI to visualize bone defects 
repaired with CPC was tested, with the incorporation of ultra-small particles of iron oxide and 
Gd-DTPA. CPCs and contrast agents containing CPCs became visible in MRI post implantation.
In Chapter 4, we further develop the approach described in chapter 3, now aiming to evaluate 
the feasibility of a dual contrast agent, traceable with both CT and MRI, as enhancers of CPC/
bone tissue contrast. Silica beads were used to encapsulate and carry contrast-enhancing 
nanoparticles, including colloidal gold and superparamagnetic Iron oxide particles (SPIO). The 
bead suspension was incorporated within a calcium phosphate powder. The resultant cements 
were then tested both in vitro and in vivo in a rat femoral condyle defect model.
Improving the non-invasive assessment of bone tissue regeneration is essential to optimize the 
stages of bone healing using CPC. In addition it would be advantegous if the osteogenic properties 
of CPC can be improved. The osteo-inductivity of these materials can be enhanced by incorporating 
biologically active molecules, like bone morphogenetic protein (BMP-2). In Chapter 5, mesoporous 
silica beads were produced containing an iron oxide core to enhance MR contrast of bone. The same 
beads were functionalized with silane linkers to immobilize the osteoinductive protein BMP-2, and 
also received a calcium phosphate coating before being embedded in the CPC. Both in vitro and 
in vivo tests were performed to test this theranostic agent (TA) for its potential to simultaneously 
enhance MR imaging and osteogenic properties of bone substitute material.
The development of bone tissue engineering and regenerative dentistry requires more 
informative imaging than X-ray. Since the main content of densely mineralized tissues such as 
bone and tooth is hydroxylapatite, a crystalline calcium phosphate, the imaging of phosphate 
content is expected to reveal a direct picture of their mineral structures and content. Such 
measurements could be realized by 31P MRI. In Chapter 6, advanced MRI approaches such 
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as SWIFT and ZTE were tested for dental 1H and 31P MR imaging. Furthermore, the 1H-31P 
heteronuclear Nuclear Overhauser Effect (NOE) was explored for 31P spins by saturating nearby 
protons, to investigate if it could generate structural contrast and enhance the 31P signal in 
images. Finally, the differences in NOE dynamics between dentin and enamel were further 
investigated in a series of solid-state NMR experiments.
A summary of the findings described in this thesis is provided in Chapter 7, and an overview for 
some possible future studies is described in Chapter 8.
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aBstract
Noninvasive monitoring of implanted scaffolds is important to understand their behavior and 
role in tissue engineering, in particular to follow their degradation and interaction with host 
tissue. MRI is well suited for this goal, but its application is often hampered by the low contrast 
of scaffolds, which are prepared from biomaterials such as type I collagen. The aim of this study 
was to test if iron oxide particles added to type I collagen scaffolds improved their MRI contrast, 
and to follow their degradation and tissue interactions. Scaffolds with and without iron oxide 
particles were implanted either subcutaneously or on the bladder of rats. At pre-determined 
time points MR images were obtained and tissues were harvested for analysis. Incorporation 
of iron oxide particles improved the MRI contrast of the implants, providing information on 
their location, shapes and degradation. MRI also revealed that the degradation and host 
tissue reaction of iron particles loaded scaffolds differed between subcutaneous and bladder 
implantation, which was substantiated by histology.
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1. introduction
Tissue engineering aims to repair or replace tissues and organs1. The major classes of materials 
to fabricate scaffolds in tissue engineering are synthetic polymers, and natural derived 
substances (biomaterials)2. Before clinical implementation can be achieved, their performance 
in vivo needs to be established. Currently, the quality and the degradation of scaffolds and tissue 
remodeling is mainly investigated in animals post-mortem. Unfortunately, the remodeling and 
regeneration process remains somewhat obscure, as longitudinal follow-up of the same animal 
is not possible. Non-invasive monitoring of the materials can greatly assist in understanding of 
the remodeling process and the effectiveness of the scaffold in regenerating and supporting 
tissues. For bone tissue engineering, imaging modalities like micro-computed tomography 
(µ-CT)3,4,5 and magnetic resonance imaging (MRI)6,7,8 have been used. In contrast, proper tools 
are missing for the imaging of materials used in soft tissue engineering: X-ray, ultrasound and 
optical imaging are limited by radiation exposure, the lack of contrast and  penetration depth9. 
Collagen has been used to fabricate scaffolds for functional genitourinary tissue10 and in 
skin tissue engineering11. Type I collagen based scaffolds showed many advantages in soft tissue 
engineering, and its design and optimization has been investigated quite extensively12,13,14,15,16.  We 
also have used collagen scaffolds to engineer urethral and bladder tissue in animal models17,18.
The human urinary bladder wall can be visualized in T
2
-weighted MR images, because its 
signal intensity is low, while both the urine and the perivesical fat have high signal intensities19. 
Most MR imaging of engineered bladder tissue has been restricted to in vitro studies20,21,22. 
Monitoring the degradation of type I collagen scaffold as bladder implant is challenging: the 
high signal intensities regions, the irregular and individual shape of each bladder, the similarity 
of the material to adjacent normal tissue and the ambiguity to identify remodeled tissues make 
interpretation difficult. MRI of bladder implants in rodents is particularly challenging because 
their small size aggravates the former difficulties.
In this study, iron oxide particles were incorporated into type I collagen scaffolds to generate 
contrast for visualization by MRI. Iron oxide particle loaded scaffolds were implanted either 
subcutaneously or on the bladder of rats, to monitor scaffold degradation. MR images were obtained 
at predefined time-points and were compared with histological analysis.
2. Matherials and Methods
2.1. scaffold preparation, contrast agent incorporation and analyses
The collagen scaffolds (COL) were essentially prepared as described13. In brief, collagen was 
isolated from bovine achilles tendon using extractions with diluted acetic acid, sodium chloride, 
urea, and acetone solutions. A 0.67 wt% collagen suspension was prepared by mixing insoluble 
type I collagen with 0.25M acetic acid. After 16 hours at 4°C, the suspension was homogenized 
using a Potter-Elvehjem homogenizer, centrifuged to remove air and poured into a mould, frozen 
and lyophilized, resulting in porous scaffolds. Cross-linking was achieved using 1-ethyl-3-(3- 
dimethyl aminopropyl) carbodiimide (EDC) in combination with N-hydroxysuccinimide (NHS), 
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to strengthen the scaffolds. Ultra-small super paramagnetic iron oxide particles (USPIO, Thermo 
Scientific, USA), 10nm in diameter, were dissolved in acetic acid (1:4 in volume) before suspending 
the collagen, to fabricate the contrast agent loaded scaffold (COL-USPIO). The rest of the process 
was as described above. Scaffolds were extensively washed using phosphate buffered saline (PBS). 
Thereafter, all scaffolds were transferred to 70% ethanol and stored at -20°C until use.
The distribution of the iron particles and morphology of the scaffolds was analyzed using 
transmission electron microscopy (TEM). The samples were incubated on formvar-coated grids for 
1 hour at 21°C, washed with 0.1 M phosphate buffer (pH 7.4), then washed two times with MilliQ water, 
stained with 0.1% (w/v) uranyl acetate, and finally examined in a JEOL 1010 TEM (Tokyo, Japan).
2.2. experimental design and surgical procedure
Animal experiments were performed according to local and national guidelines and after 
approval of the local IACUC (Institutional Animal Care and Use Committee). Adult male WAG/
Rij rats were housed in temperature-controlled cages at 50%–55% humidity with a 12 hours 
light–dark cycle and free access to standard laboratory chow and tap water. Rats were divided 
into 3 groups (with 6 animals each), which were evaluated post-surgery at two, four and twelve 
weeks. Surgery was performed under general anesthesia (induction: isoflurane (2-5%), followed 
by isoflurane (2%)/ air (1 L/min) and sterile conditions. Pre-operative Rimadyl (5.0 mg/kg) and 
morphine (1.0 mg/kg) was administered subcutaneously to reduce postoperative pain. Before 
implantation scaffolds were washed extensively with PBS. Scaffolds (1 cm in diameter) were 
implanted subcutaneously and on the bladder in the same animal, with one USPIO loaded and 
one unloaded scaffold. During the following 2 days, post-operative pain medication (temgesic 
0.02 mg/kg) was administered subcutaneously. After evaluation by MRI at predetermined time-
points, the animals were sacrificed by CO
2
 overdose and materials were harvested.
2.3. Mr imaging
MR images were obtained on a 7T animal MR system (Bruker, Clinscan, Germany), equipped with 
a surface coil (3.5cm*3.5cm). T
2
-weighted images and T
2
 relaxation time measurements were 
performed on control (COL) and iron oxide loaded collagen scaffolds (COL-USPIO). The standard 
parameters for in vitro imaging by a turbo spin echo sequence were: flip angle=30 degrees, 
FOV=40*40 mm, TR=2000 ms, TE=20 ms, slices thickness=1 mm, turbo factors=4, matrix 128*128. 
To measure apparent T
2
 values, several images were captured using the same parameters but 
with different echo time (TE= 10, 20, 40, 60, 80, 100, 120, 140ms). Signal intensity versus echo 
time was fitted into a single exponential decay to calculate the apparent T
2
 relaxation time. 
In vivo MRI was performed using a similar 2D turbo spin-echo sequence (instead of a 
gradient-echo sequence, to minimize blooming and other artifacts). The surface coil was 
placed adjacent to the scaffold location, the FOV was 40*40 mm, TR=2000 ms, TE=14 ms, with 
20 slices, slice thickness 0.5mm, turbo factor=4, matrix size 256*256; the total scanning time 
was 20 minutes. Images were acquired under general anesthesia post-operation, at two, four 
and twelve weeks. A urinary catheter was inserted into the rat bladder before scanning, to 
facilitate filling of the bladder with PBS to maintain bladder volume.
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The volumes of implanted scaffolds were assessed from the MR images by manually outlining their 
extension in each image slice using ImageJ. The entire volume was then calculated by multiplying 
the sum of these areas with the slice thickness (1 mm). Scaffold volumes were estimated for the 
subcutaneous implants immediately post-implantation, and at two and four weeks thereafter. For 
each group (COL and COL-USPIO), the average volumes with standard deviation (from 3 animals) 
were evaluated by Graphpad Prism (Graphpad Software).  The rim thicknesses of subcutaneous 
implants were also measured at week 2 and week 4 (ImageJ). The average of the maximum thickness 
of capsules from the central region of COL and COL-USPIO scaffolds were listed. 
2.4. immunohistological examination
Harvested scaffolds were macroscopically inspected, formalin-fixed and paraffin embedded. 
Sections were cut (5 µm), deparaffinized and hydrated through a graded series of ethanol and 
stained with haematoxylin and eosin (H&E). To investigate the distribution of iron particles, 
sections were stained with Prussian Blue23.
3. results
3.1. teM and In vitro Mr evaluation of scaffold
The collagen fibrils in the scaffolds showed a striated banded pattern (Fig.1-A and B). The USPIO 
particles were homogenously distributed in the COL-USPIO scaffolds (Fig.1-B), even 4 weeks 
after implantation in vivo. (Fig.1-C). 
From the decay of signal intensity of scaffolds versus echo time, the following T
2
 relaxation 
times were calculated: 22.8±3 ms for COL-USPIO and 80±10 ms for the plain scaffold (COL) 
scaffold. The decreased T
2
 of the COL-USPIO scaffold resulted in enhanced contrast: the region 
of hypo-intensity in the MR image represented the scaffold (Fig. 2A), whereas the COL scaffold 
almost vanished in the background signals (Fig. 2B).
Figure 1. Ultra-structural localization of iron particles in the collagen scaffold (images of TEM). A) Plain collagen 
scaffold (COL), B) USPIO loaded collagen scaffold (COL-USPIO), C) USPIO loaded collagen scaffold after 4 weeks 
implantation. Small red arrows: collagen fibrils with striated banded pattern. White arrows indicate the small iron 
particles. Bar represents 200 nm.
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3.2. histological evaluation of implanted scaffolds
Small cellular accumulations were observed at the periphery of the plain COL scaffolds, 
consisting of fibroblasts, macrophages, and some PMNs (polymorphonuclear leukocytes), 
lymphocytes and giant cells (Fig.3-a). A cellular rim was present at the outer margins of the 
scaffold at week two in almost all scaffolds. At week four, giant cells, macrophages and some 
lymphocytes were still present. After twelve weeks, the number of infiltrating cells was similar 
but cells were more evenly distributed, and small capillaries with erythrocytes were present 
(Fig.3-e). Both at four and twelve weeks post-surgery, an increase of extra cellular matrix (ECM) 
formation between the COL scaffolds and the native tissue was observed (Fig.3-k). No major 
differences were observed between the subcutaneous skin and bladder COL implants.
In COL-USPIO bladder implants, more PMNs, macrophages, fibroblasts and lymphocytes 
were observed at the outer margins compared to the subcutaneous implant, both after 2 and 4 
weeks. Analysis of COL-USPIO scaffolds 12 weeks post bladder implantation demonstrated many 
macrophages and giant cells dispersed throughout the scaffold, whereas this was much less 
apparent in skin implanted COL-USPIO scaffolds (Fig.3-f, l). Small capillaries were observed at 2, 4 
and 12 weeks in the COL-USPIO bladder group (Fig.3-b, f) comparable to COL-scaffolds 12 weeks 
post-implantation. Bladder implanted COL-USPIO scaffolds always showed higher cellular infiltration 
density as compared to the plain COL scaffold at all time points. In contrast, COL and COL-USPIO 
scaffolds showed comparable cellular infiltration density in the subcutaneous implants.
Prussian blue staining, used to visualize iron, demonstrated the presence of iron-containing 
cells in the COL-USPIO loaded groups. Signs of positive Prussian blue could still be detected in 
material harvested 12 weeks post-implantation (Fig. 4).
Figure 2. T
2
-weighted imaging of plain scaffold and COL-USPIO in an Eppendorf tube filled with PBS. A. USPIO 
loaded collagen scaffold(COL-USPIO), the region of hypointensity represents the scaffold. B. Plain collagen 
scaffold, the scaffold is almost invisible due to the lack of contrast.
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Figure 3. H&E staining of sections from surgically removed skin and bladder implant. Pictures a-f are from bladder 
implants, pictures g-l are from skin implants. Bar represents 200 µm. G: Giant cells. n: newly formed extra cellular 
matrix. c: new capillaries. COL: Plain collagen scaffold. COL-USPIO: USPIO loaded collagen scaffold.
Figure 4. Perls’ Prussian blue staining of 
the bladder and subcutaneous implants 
(skin) after 12 weeks’ implantation. COL: 
plain collagen scaffold. COL-USPIO: iron 
oxide particles loaded collagen scaffold. Bar 
represents 200 µm.
3.3. Mr imaging
Subcutaneous region
For the subcutaneously implanted COL scaffold, the T
2
 weighted imaging clearly discriminated 
between the host tissue and the collagen implant (Fig. 5): the hyperintense region represented 
the shape and volume of the implant. Moreover, a capsule was present at the outer margins 
after two weeks and a rim was visible (Fig. 5, red arrows), most likely representing the cellular 
rim observed in the histological examination. At later time points the COL scaffold was still 
detectable, but with a reduced volume. At four weeks, a significant decrease in the volume was 
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observed, while the rim of capsule present at the outer margins of the scaffold post-surgery 
was still visible. The scaffold became undetectable 12 weeks post-implantation. 
The subcutaneously implanted COL-USPIO constructs rapidly degraded as judged by 
MRI: the central hypointense region disappeared two weeks after implantation and only 
some contrast remained visible in the periphery of the scaffold (Fig. 5). After 4 weeks, the 
hyperintense region in the scaffold became negligible (Fig. 5). From this time point onwards, 
the MR image of the COL-USPIO scaffold is very similar to the subcutaneously implanted COL 
scaffold but much smaller. The average volume of the COL-USPIO implants decreased similarly 
to the COL implants until week two, but was lower at week four (Fig. 6).
Figure 5. T
2
-weighted MR imaging of animals with subcutaneously implanted scaffolds, immediately after 
implantation and at 2, 4, 12 week post-implantation. In the COL group, a hyperintensity region was seen. A clear 
rim could be observed at week 2, and it still existed at week 4. The size of the region decreases after implantation, 
and finally disappeared at week 12. The COL-USPIO presented as a region of hypointensity (yellow arrows), 
but the contrast quickly disappeared. After 2 weeks it was only present in the periphery of the implant. The 
decrease in size was faster for the COL-USPIO; the signal from the scaffold was mostly gone after 4 weeks, and 
not detectable at week 12. Yellow arrows point to the scaffolds, red arrows point to the rim. COL: plain collagen 
scaffold. COL-USPIO: iron oxide particles loaded collagen scaffold.
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Figure 6. MRI measured volumes for COL and COL-
USPIO, from week 0 till week 4. 
Table 1. The maximum thickness at the central region of COL and COL-USPIO implanted subcutaneously, at 
week 2 and week 4.
Maximum thickness (mm) Week 2 Week 4 
COL-USPIO 0.45±0.09 0.22±0.03 
COL 0.3±0.04 0.15±0.03 
Measurements of maximum thickness of the capsule in the central region of the scaffold 
clearly showed that the COL-USPIO implants had a thicker rim compared to the COL implants, 
at both week 2 and week 4 (Table. 1).
Bladder region
COL scaffolds implanted on the bladder could not be detected by MRI (Fig. 7) due to the 
hyperintensity of the fluid in the bladders. In animals in which COL-USPIO were implanted on 
the bladder, a hypointense region was observed, identifying the location and shape of the 
implant (Fig. 6). Two weeks after implantation, the size of the hypointense region decreased, 
and was further reduced but still visible up to 4 weeks. At the last time point, 12 weeks post-
implantation, no sign of the contrast agent was apparent on T
2
-weighted imaging.
4. discussion
In this study we investigated the feasibility of in vivo MR imaging to monitor engineered soft 
tissue scaffolds, assisted by iron oxide particles incorporation. Regular and USPIO loaded 
collagen scaffolds were implanted subcutaneously or on the bladder. We demonstrated that 
collagen scaffolds on the bladder could only be visualized by MRI with iron oxide doping. 
Additionally, we observed that the scaffold behavior such as degradation and the tissue reaction 
depended on the site of implantation.
In regenerative medicine the proper assessment of the degradation of engineered materials 
and of tissue remodeling requires longitudinal monitoring, ideally non-invasively and throughout 
the entire time span of these processes. MRI is particularly suited for this goal as it provides sub 
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millimeter anatomical resolution without radiation and restriction of penetration depth, and 
offers contrast for both dense tissue and soft tissue. Moreover, it also can provide quantitative 
information24, 25. Thus far, few MRI studies have addressed imaging of bladder tissue implants, 
and these mostly focused on measurements of vascularity, using a blood-pool contrast agent26, 
without showing long-term follow up of scaffold remodeling. To the best of our knowledge, in 
vivo MRI monitoring implants on a small animal bladder has not been described. 
In our study of bladder implantations, only the COL-USPIO scaffolds could be visualized and 
followed longitudinally. In these scaffolds, the homogenously distributed USPIO perturb nuclear 
Figure 7. T
2
-weighted MR imaging the bladder of the rat, immediately post-implantation and at 2, 4, 12 weeks 
thereafter. The COL implant is not visible at all, no change could be observed from week 0 till week 12. In the 
COL-USPIO implanted animals, the scaffold was observed as a hypointense region (red arrows). After 2 weeks, 
this hypointense region was substantially decreased.  At week 4, a small region of hypointensity was still visible, 
whereas no sign of iron oxide generated contrast was observed at 12 weeks. 
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spin relaxation processes of surrounding protons from water molecules27. On T
2
-weighted MR 
images, this resulted in hypointense regions which improved contrast and visibility of the 
scaffold implanted on the bladder. These hypointense regions were still visible up to 4 weeks, 
but not at 12 weeks post-implantation. This indicated that the level of USPIO particles present 
in the remaining scaffold was not sufficient for a complete follow-up, as the degradation of the 
scaffold was still in progress according to the histological analysis. 
In the MRI of the subcutaneous implantation, the COL scaffold showed a hyperintense 
region immediately post-implantation. This most likely represented the stored bulk water 
present in the honeycomb structure and large interstitial spaces of the collagen scaffold28. 
After implantation, the PBS in the scaffold would be replaced by body fluids, maintaining the 
hyperintense appearance of the scaffold in MR images. In contrast, the COL-USPIO scaffold 
showed a region of hypointensity but this quickly disappeared within 2 weeks. From then on 
both the COL and COL-USPIO scaffold appeared as hyperintense regions up to week 4. After 
that the COL-USPIO scaffold appeared to degrade faster than the COL scaffold.
In our study, USPIO incorporation caused no apparent changes in scaffold morphology. 
In contrast, doping with another commonly used MR contrast agent, gadolinium with 
diethylenetriaminepentaacetic acid (Gd-DTPA), destroyed the 3D structure of the scaffold during 
fabrication (results not shown). Quantification of the iron oxide particle content in the COL-USPIO 
scaffolds is complex. First, the scaffolds were intensively washed, causing an unknown decrease of 
incorporated particles. Secondly, it is difficult to quantify the amount of particles based on their 
MR signal decrease. Thus for quantitative assessments, new approaches in MR contrast are needed. 
The implantation of the scaffold resulted in an inflammatory response, which was associated 
with the occurrence of polymorphonuclear cells and macrophages in the scaffold environment 
in agreement with other studies29. An invasion of a large number of macrophages was seen, in 
particular at the peripheral zone of the scaffold, which corresponded with MR observations. 
In MRI, this foreign body response was reflected by a hypointense capsule at the rim of the 
hyperintense region in the image of the subcutaneous COL implant. The thickness of the capsule 
could be used as an indicator of the biocompatibility of the material: biomaterials with poor 
biocompatibility are generally covered with thicker capsules, which restrict angiogenesis and 
integration30. We observed an enhanced foreign body reaction for the COL-USPIO scaffolds (a 
thicker capsule in MRI): the capsule from subcutaneous COL-USPIO implants was always thicker 
than the capsule from COL implants. This indicates that USPIO incorporation leads to a more 
severe inflammatory response, but there were no signs of iron oxide related toxicity and it is 
very unlikely that the scaffolds contain amounts beyond their safety level (2.6 mg Fe/kg)31. Our 
assumption is this thicker capsule is due to more severe apparent inflammatory response by the 
introduction of iron particles32 and the hypointensity because of iron particles residuals. More 
detailed information of the capsule could be obtained by higher resolution and/or functional 
MRI, but this usually requires longer scanning time, which is not ideal for in vivo studies. 
In this study, we also found that the remodeling of the COL-USPIO scaffold depended on 
the implantation site; e.g. it was associated with more reactive cellular influx at the bladder site. 
It is likely that the different tissue microenvironment resulted in different degradation rates, 
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cell response and remodeling. Our results agree with other studies showing the importance of 
the microenvironment for the result of tissue engineering33, and also with observations in the 
interaction between tumor and organ-specific factors34. Thus it is imperative to test the imaging 
capability and behavior of a specific scaffold at its target tissue or organ. This will be particularly 
important for ”smart scaffolds” that contain tissue specific cues such as growth factors.
Future studies could make use of the many imaging options of MR to improve evaluation of 
implants, such as quantitative MR measurements of in vivo T
1
 and T
2
 relaxation times or diffusion 
and perfusion processes. Apparent diffusion coefficient (ADC) values would enable a non-
direct measurement of the capsule density, since the dense capsule restricts the movement 
of free water36. MR cell labeling could be used to monitor transplanted cells and their behavior 
in the implant over time and under different physiological conditions. Moreover, gadolinium 
and iron oxide based contrast agents can be injected, to track (neo)vasculature and measure 
vessel density. Non-invasive longitudinal experiments also can reduce the number of animals 
commonly used in the midterm experimental evaluation. 
5. conclusion
Our study indicates that next to regular histological analysis, longitudinal MRI of USPIO loaded 
collagen scaffolds can reveal its location, size and degradation, even at challenging anatomical 
locations. This demonstrated that degradation at different implantation sites might not be the 
same. Such information is valuable in guiding the further development and evaluation process 
of type I collagen scaffolds in soft tissue engineering. 
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aBstract
Calcium phosphate cements (CPCs) are widely used bone substitutes. However, CPCs have 
similar radiopacity as natural bone, rendering them difficult to be differentiated in classical X-ray 
and computed tomography imaging. As conventional magnetic resonance imaging (MRI) of 
bone is cumbersome, due to low water content and very short T
2
 relaxation time, ultra-short 
echo time (UTE) and zero echo time (ZTE) MRI have been explored for bone visualization. This 
study examined the possibility to differentiate bone and CPC by MRI. T
1
 and T
2
* values determined 
with UTE MRI showed little difference between bone and CPC; hence, these materials were 
difficult to separate based on T
1
 or T
2
 alone. Incorporation of ultra-small particles of iron oxide 
and gadopentetatedimeglumine (Gd-DTPA; 1 weight percentage [wt%] and 5 wt% respectively) 
into CPC resulted in visualization of CPC with decreased intensity on ZTE images in in vitro and 
ex vivo experiments. However, these additions had unfavorable effects on the solidification time 
and/or mechanical properties of the CPC, with the exception of 1% Gd-DTPA alone. Therefore, 
we tested this material in an in vivo experiment. The contrast of CPC was enhanced at an early 
stage postimplantation, and was significantly reduced in the 8 weeks thereafter. This indicates 
that ZTE imaging with Gd-DTPA as a contrast agent could be a valid radiation-free method to 
visualize CPC degradation and bone regeneration in preclinical experiments.
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1. introduction
To heal bone tissue loss and damage, autologous grafting remains the preferred clinical option. 
However, autograft material is scarce and thus the implantation of synthetic bone grafts at the 
site of injury is sometimes necessary.1 Among a large number of available bone substitutes, 
calcium phosphate cement (CPC) best resembles the matrix of natural bone. The high similarity 
of CPC to natural bone not only promotes bone regeneration, but also results in low contrast 
between CPC and native bone tissue in X-ray and computed tomography (CT) imaging. 
Therefore, it remains difficult to monitor the degradation of the cements and regeneration 
of bone tissue, hampering the evaluation of repair procedures. A strategy to overcome this 
problem is the addition of contrast agents to CPC. For example, contrast agents with iodine, 
barium, and tantalum have been utilized in X-ray to increase radiopacity of CPCs, which allowed 
discriminating them from bone tissue.2–5 X-ray imaging provides adequate resolution with high 
throughput at low cost, but with relatively poor contrast and potential radiation damage.6
Magnetic resonance imaging (MRI) is a noninvasive, radiation-free, high-resolution technique, 
which however is mostly optimized to visualize soft tissues. The MR signals are generated from 
the proton spins in water molecules, if placed in a strong magnetic field, by a radiofrequency (RF) 
pulse. In an explorative animal study, it was shown that MRI could be a valuable tool in bone tissue 
engineering.7 However, due to a relatively low content of water protons and their ultra-short T
2
 
relaxation (e.g., cortical bone has a mean T
2
 value of 500 µs or less8), MRI of rigid tissue and solid 
material is still challenging. Some approaches that have been proposed to image hard tissues are 
solid-state and single-point MR techniques,9,10 but these are unfavorable for in vivo applications 
due to long acquisition times. Following improvements in hardware and MR methods, an echo 
time of less than hundreds of µs could be reached by ultra-short echo time (UTE) imaging either 
employing a short nonselective RF excitation pulse with 3D radial sampling or using a two half-pulse 
free induction decay (FID) acquisition.11,12 Suppression of long-T
2
 spins from soft tissue have further 
improved and extended this technique and its derivatives.13,14 More recently, a no-echo-time method 
called sweep imaging with Fourier transformation (SWIFT) was introduced, which acquires data 
quasi-simultaneously with the excitation pulse, using adiabatic pulses. It already has been applied 
in imaging of bone samples and thermoplastic objects.15, 16 Another approach without echo time 
spin evolution is zero echo time (ZTE) MR.17–20 It is closely related to UTE and has been implemented 
on small animal MR systems.21 A hard RF pulse is applied to accomplish spatially nonselective 
excitation that covers the full frequency bandwidth spanned by the readout gradient. Excitation and 
acquisition is both in the presence of a constant gradient purely used for frequency encoding by 
3D radial center-out k-space trajectories. Thus, these recently developed MR methods offer new 
options to image bone and might also be applicable to examine bone filler material.
The aim of this study was to explore bone and CPC imaging by the ZTE method, and to 
evaluate the incorporation of two clinical MRI contrast agents, ultra-small particles of iron oxide 
(USPIO) and gadopentetatedimeglumine (Gd-DTPA). This included the determination of useful 
contrast levels for in vivo experiments, the characterization of changes in the properties of CPC 
after addition of contrast agents, the measurement of T
1
 and T
2
* relaxation times of materials and 
surrounding bone, and finally monitoring the substitutes’ degradation in an in vivo experiment.
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2. Matherials and Methods
2.1. injectable cPc preparation and contrast agents incorporation
Calcium phosphate cement consisted of 85% α-tricalcium phosphate, 10% dicalcium phosphate 
dihydrate and 5% hydroxy apatite. The liquid applied to make cement was a sterilized 2 wt% 
(weight percentage) aqueous solution of sodium phosphate (Na
2
HPO
4
). Poly (lactic-co-
glycolic acid) particles (PLGA ,Purasorbs, Purac, Gorinchem, the Netherlands) with a lactic-
to-glycolic-acid ratio of 50:50 was used for microparticle preparation (Habraken et al. 2006). 
PLGA was mixed with the cement powder at 20 wt% to create micro-porosity. The mixture was 
sterilized using gamma radiation with 25 KGy (Isotron B.V., Ede, The Netherlands). After adding 
a filtered sterilized (0.2 µm filter) 2% aqueous solution of sodium phosphate to the PLGA/CPC 
powder, the mixture was put into a 2-mL syringe (BD Plastipak, Becton Dickinson S.A., Madrid, 
Spain) with a closed tip. These components were shaken for 20 seconds with a mixing apparatus 
(Silamat, Vivadent, Schaan, Liechtenstein) to generate injectable CPC. For the incorporation 
of USPIO (Sinerem®), it was directly added to the liquid Na
2
HPO
4
 solution with cement before 
mixing. From a USPIO solution of 21 mg/ml, 120 µL and 600 µL were applied for 1 wt% and 5 
wt% USPIO-CPC respectively. Gd-DTPA particles (MagneVist®) were incorporated within the 
cement powder after freeze drying, 6 µL and 30 µL were taken from a solution of 469 mg/ml to 
make 1 wt% and 5 wt% Gd-DTPA-CPC respectively.  
2.2. cPc characterization
The solidification times measurement and compression tests to ensure sufficient clinical 
handling proprieties of the CPC were performed as follows:
Setting time: the time required to reach a certain compressive strength.22 Initial and final 
setting time of different formulations were assessed by using custom available Gillmore needles 
(ASTM C266). Pre-set scaffolds at a size of 3 mm (diameter) x 6 mm (height) were made from a 
plastic mould. Samples from each formulation were mixed and injected into the mould, and then 
both initial and final setting times were determined. Tests were performed at room temperature.
Compression test: samples were placed in a testing bench (858 MiniBionixII®, MTS, Eden 
Prairie, MN, USA) and compressive strength and E-modulus in the longitudinal direction 
(parallel to the long axis) of the specimens were measured at 0.5 mm/min crosshead speed. 
For both tests, data are presented as mean ± standard deviation. Significant differences were 
determined by analysis of variance (ANOVA). Calculations were performed using GraphPad Instat® 
(GraphPad Software, San Diego, CA). All differences were considered significant at P-values <0.05. 
2.3. In vitro and ex vivo test of cPc repaired bone
For in vitro tests bone blocks of 1.5 cm3 were harvested from pig bone. A cylindrical defect of 
3 mm in depth and diameter was drilled using a dental bur and dental drills. Defects were then 
filled with injectable CPC. The filler material was tested with contrast agent (USPIO or Gd-DTPA) 
in different concentrations (1% and 5%) for each formulation. CPC without contrast agents were 
applied as control. Photos of bone blocks were taken, and then the MR images were acquired.
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The feasibility to use USPIO as contrast agent for localization of bone filler was also tested 
on a rat cadaver. A cylindrical defect of 3 mm depth and diameter was drilled in the femoral 
condyle, and subsequently this defect was repaired with CPC containing 1 wt% USPIO.
2.4. In vivo animal model
National guidelines for care and use of laboratory animals were obeyed with approval of the 
Experimental Animal Ethical Committee of the University Medical Center Nijmegen (RU-DEC 2010-
225). In two healthy adult male Wistar rats, weighting 250-300g, femoral condyle defects were 
created. The first rat had a defect in one leg repaired by CPC and one healthy leg, while the second 
rat had a defect in one leg repaired with Gd-DTPA-CPC and a defect on the other leg left unrepaired. 
The Gd-DTPA concentration was 1 wt% of the cement powder. Surgery was performed under 
general inhalation anesthesia (Isoflurane) and sterile conditions. Animals were immobilized and legs 
were shaved, washed and disinfected before surgery. The knee joint became totally exposed after a 
longitudinal parapatellar incision. At the femoral intercondylar notch a cylindrical defect of 3.0 mm 
depth and diameter was prepared using a dental bur and continuous external cooling with saline. 
Defects were then filled with the proper material or left unrepaired before closing.
2.5. t
1
 and t
2
* measurement using ute
The UTE sequence (see Fig.1 for basic pulse sequence) was applied to measure T
1 
(spin-lattice 
relaxations time)
 
and T
2
* (relaxation due to spin-spin interactions and field inhomogeneities), 
of two bone samples (harvested from the rat leg) with defects which had been repaired with 
CPC and Gd-DTPA-CPC respectively.  The standard parameters were: TR=8 ms, FOV=30*30*30 
mm, matrix size: 128*128*128, and 8 averages. 
In order to measure T
2
* values, several images were obtained with different echo times. As 
femoral head and CPCs bone fillers have extremely short T
2
* relaxation time, echo times were 
mostly chosen in the initial signal decay part after the 5° excitation pulse, i.e. at 40, 60, 80, 100, 
200, 400, 600, 800 and 1000 µs.
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Figure 1. Left: 3D UTE sequence, 3D radial sampling applied after nonselective RF excitation pulse, 
TE 
min
=t 
pulse
/2+delay. Delay is the time to switch from transmit to receive mode.  Right: ZTE pulse sequence, 
excitation and acquisition are both in the presence of constant gradient, with effective echo time of zero.
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Assuming a mono-exponential decay the signal intensity (S
TE
) is related to the echo time 
(TE) according to the equation23,24:
S
TE
=S
0
×e-TE/T2*+C
S
0
 is the initial value of signal intensity and C is the background noise. By fitting this equation to 
the experimental data, the T
2
* relaxation time was calculated.
For T
1
 measurements, the variable flip angle method [25] was applied. The steady state 
signal achieved when TR>>T
2
*, result in following equation for signal intensity: 
S
α
=NM
0
e-TE/T2* sinα(1-e-TR/T1)/ 1-cosα(e-TR/T1)
N represent a constant, M
0 
is the net magnetization at thermal equilibrium and α is the flip 
angle. This equation can be rearranged to:
S
α
/sinα=e-TR/T1S
α
/tanα+NM
0
e-Te/T2*(1-e-TR/T1)
Linear regression is independent of N, T
2
* and TE allowing the calculation of T
1
. By using variable 
flip angles (α=2.5°, 5°, 7.5°, 10°, 12.5°), TE=0.04ms and other standard parameters in UTE, images 
with signal intensity as a function of T
1
 were obtained.
Regions of interests (ROIs) were manually outlined on the bone filler and about the same 
number of pixels on femoral head using Paravision 5.1(Bruker, Biospin, Germany). Average 
signal intensities of a selected region on UTE images were calculated using the same program, 
and then processed in GraphPad Prism® (GraphPad Software, San Diego, CA, USA).
2.6. Mr imaging
MR imaging of bone samples was performed on an 11.7T MR system (Biospec, Bruker, Germany) with 
a home-built Helmholtz coil, with a size of 3*3 cm. The standard ZTE imaging (ZTE pulse sequence 
diagram is shown in Figure 1) was done with 200 kHz bandwidth, pulse length=0.002 ms, TR=4 ms, 
FOV = 50*50*50 mm, matrix size: 128*128*128, 1 average and a total acquisition time of 3 mins 27 secs. 
Conventional MR imaging of bone was acquired with 3D RARE, with FOV = 50*50*50 mm, TE/TR=35.7 
ms/1000 ms, RARE factor=16, and acquisition time of 8 mins 32 secs. ZTE imaging of cadaver rats 
were performed on the same MR system and using the same acquisition parameters.
For in vivo experiments, ZTE imaging was done right after surgery and 8 weeks post operation 
on 2 animals with similar parameters as in the standard acquisition protocol, but with TR=8 ms, 
4 averages and a total acquisition time around 30 minutes. Because the use of a ZTE sequence, 
other rigid material such as the animal bed, and holders, water heating system and RF coil housing 
may give background signal. Therefore, proton free materials were applied wherever possible.  
2.7. In vivo ct imaging
For comparison with MRI, the non-defect leg was imaged on a small animal scanner (Inveon®, 
Siemens Preclinical Solutions, Knoxville, TN, USA). Scans were performed under general 
inhalation anesthesia (Isoflurane). The animal was placed in a supine position in the scanner and 
images were acquired over ~6 minutes (spatial resolution 30.04 µm, 80 kV, 500 µA, exposure 
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time 1000 ms, frame average by 1). CT values of air (-1000 HU) and water (0 HU) were applied to 
calibrate the image values in Hounsfield units, while the bone mineral density values provided 
a linear calibration for bone mineral density values. CT images were reconstructed using a 
modified cone-beam algorithm.26
3. results
3.1. cPc characterization
For CPC doped with USPIO at concentrations of 1 wt% and 5 wt%, the initial and final setting 
times were substantially prolonged compared to normal CPC (Table 1). For the formulations with 
1 wt% and 5 wt% Gd-DTPA no significant change in final setting times compared to normal CPC 
was observed. Compression tests of CPC with 5% Gd-DPTA and 5% USPIO showed a significant 
decrease of the peak load (Table 1). In contrast, adding 1% Gd-DPTA and 1% USPIO did not result 
in a significant change. In conclusion, the setting time and the mechanical properties of CPC 
were not affected by adding 1% Gd-DTPA. 
3.2. In vitro and ex vivo imaging of repaired bone
Visual inspection of pig bone blocks repaired with pure CPC revealed a white lesion with a sharp 
edge, making the cement easily discernible from bone (Fig. 2A). In MR images there was little 
contrast between bone and CPC, even in image obtained by ZTE (Fig. 2E). For the Gd-DTPA 
incorporated CPCs filler, visual inspection showed the same contrast as for pure CPC (Fig. 2B), 
but with enhanced contrast in ZTE imaging (Fig. 2F). Finally, with USPIO incorporation the 
lesion became black (Fig. 2C, d) and showed large effects on ZTE images, due to the so called 
“blooming effect” of the iron oxide particles (Fig. 2g, H). 
To test the feasibility of applying USPIO as a contrast agent in animal experiments, an 
ex-vivo experiment was performed on bone defect repaired by 1 wt% USPIO tagged CPCs, since 
the lower concentration had less effect on the properties of CPC. On conventional MRI, bone 
and normal CPC both appear dark (Fig. 3A), with little bone detail. In contrast, bone structure 
is clearly seen on the ZTE images (Fig. 3B). However the strong blooming effect rendered the 
precise localization of USPIO-CPC filler cumbersome, also in ZTE imaging (Fig. 3B).
Table 1. Setting time and compression test. To determine the setting time a standard Gillmore test was used, 
initial needle diameter 1/12 inch, Weight ¼ lb; Final needle diameter 1/24 inch, Weight ¼ lb. 
Gillmore Test  
&compression test 
Initial Setting Time  
(min) 
Final Setting Time  
(min) 
Peak load  
(N) 
CPC 8,9 ± 0,53 22.0 ± 0,42 31.9± 5.05 
Gd-DTPA 1% 12,4 ± 0,55 21,4 ± 0,42 32.0± 13.61 
Gd-DTPA 5% 15,4 ± 0,34 27,3 ± 0,22 5.74± 0.39 
USPIO 1% 50,8 ± 3,09 114,5 ± 3,14 35.3± 21.77 
USPIO 5%  140,4 ± 9,34 21,3 ± 0,83 17.1± 8.02 
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Figure 2. Macroscopic views and MR images of bone samples with defect in bone blocks repaired by CPCs. The 
lesions with bone filler material are indicated by red arrows in the pictures (top, A-D) and by blue arrows in the 
MRI’s, which were obtained by ZTE imaging (bottom, E-H).  A, E. No contrast agent; B, F. with Gd-DTPA 1wt%; C, 
G. with USPIO 1wt%; D, H. with USPIO 5 wt%; note the stronger blooming effect with 5 wt% USPIO (H).
Figure 3. Ex-vivo MR images of 2 rat legs with repaired defects. A: bone and CPC appear dark and no detail is 
apparent in conventional MR imaging (3D RARE). B: ZTE image of the bone defect repaired by USPIO-CPC, bone 
details and lesion site can be discerned. Note however the strong blooming effect (arrow).
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3.3. t
1
 and t
2
* measurement of bone and bone fillers
Using 3D UTE at different echo times T
2
* relaxation times were assessed. The signal decay in 
these measurements were fitted with a mono-exponential function (see Fig. 4) resulting in T
2
* 
relaxation times of 597±19 µs for bone, 442±22 µs for CPC and 226±18 µs for Gd-DTPA-CPCs.  
For the T
1
 measurements the variable flip angle method was used. This resulted in T
1
 
relaxation time of 474.19±28 ms for bone, 527±29 ms for CPC and 336.44±25 ms for Gd-DTPA 
loaded CPCs. Thus T
1
 and T
2
* values were both shortened due to Gd-DTPA incorporation. 
3.4. In vivo imaging of cPc repaired femoral condyle defects
On ZTE images of the rat leg without defect, bone and surrounding tissues were clearly 
distinguishable (Fig. 5A). Despite that the resolution of the image of rat condyle measured by 
ZTE MRI was lower than those obtained by CT (Fig. 5B). It has sufficient image quality to provide 
complementary structural diagnostic information on bone and surrounding soft tissue like 
muscles and meniscus.
For in vivo assessment of contrast enhancement in ZTE imaging of repaired bone lesions we 
selected CPC doped with 1% Gd-DTPA, as this formulation had similar mechanical properties as normal 
CPC (without Gd-DTPA). Lesions filled with the contrast agent loaded CPC showed a decreased signal 
intensity compared to the surrounding bone tissue (Fig. 6A,B), reflecting the shortened relaxation 
times. The shape and location of the filler material were clearly visible. This contrast decreased after 8 
weeks, but it was still possible to differentiate the lesion location from bone (Fig. 6C). 
Figure 4. Signal intensity plotted versus TE in UTE acquisition of bone and CPC materials. All curves are normalized 
to 100 % signal intensity at the first measurement point. Dashed and dotted line(black): fit of T
2
* decay of CPC. 
Dotted line(green): fit of bone T
2
* decay. Red line: fit of T
2
* decay of 1 wt% Gd-DTPA loaded CPC.
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Figure 5. A: ZTE image of healthy rat condyle, soft tissues like muscles are surrounding the bone structure. B: In 
vivo CT of the same body part.
Figure 6. In vivo ZTE MR images of femoral condyle defects in rat leg. A. Femor with bone defect filled with Gd-
DTPA-CPC. B. Zoomed part of image in A, only showing the femoral condyle. D. Same condyle, 8 weeks after the 
first scan (image B). C. Condyle from another rat, with defect filled with CPC without contrast added. E. Same 
condyle 8 weeks after first scan (image C). Arrows indicate position of lesion with CPC + 1% Gd-DTPA (red) and 
CPC without contrast agent (blue). 
Lesions filled with normal CPC showed little contrast with bone on ZTE images immediately 
post-operation. This contrast was further degraded 8 weeks later, so that the lesion was virtually 
invisible (Fig. 6d,E). 
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4. discussion
In this study we demonstrated that bone defects repaired by CPC could be distinguished 
from surrounding bone on MR images by using a ZTE sequence and mixing the CPC with a 
contrast agent. Among the contrast formulations tested the clinical approved Gd-DTPA at 
1 wt% appeared to be most practical. This would enable the evaluation of bone regeneration in 
studies to optimize procedures for lesion repair.
CT has been used in the past in the imaging of repaired bone lesions. To distinguish 
bone defects filled with CPC from surrounding tissue this also requires a contrast enhancer 
(radiopacifier), such as tantalumpentoxide.28 Especially in longitudinal CT studies the 
accumulation of radiation becomes a matter of concern.6 Therefore, MRI has attracted attention 
as an alternative in the imaging of bone and hard tissue. For example, T1-weighted MRI on bone 
implants with gadolinium-based contrast clearly demonstrated the potential of MRI to study 
bone formation29 and gadoteratemeglumine was developed to enhance MRI of bone cement.30 
However, none of these experiments yet demonstrated in-vivo MRI of the material. Further, as 
only conventional MRI was used signal intensity was not optimal.
Since both bone and CPC have very short T
2
 values (<1 ms), it is problematic to visualize these 
materials with conventional MRI, as signal rapidly disappears in the echo times of several ms or 
more. A UTE sequence provides the possibility to obtain MR images at echo time below 1 ms,12 
but this sequence has some intrinsic problems, like errors from eddy-currents generated by the 
gradient ramps, which need to be corrected by k-space trajectory measurements; additionally, 
the ramp reduces the signal to noise ratio.21 Therefore, the use of ZTE imaging, which samples 
signal without an echo time delay, was explored to visualize bone and CPC at optimal signal 
strength. In this study, it was shown that with ZTE indeed good images of bone and CPC could 
be obtained. And a comparison with CT shows that interesting complementary information of 
bone may be obtained. In practice, both UTE and ZTE suffer from dominating signals of long T
2
 
spin systems, in particular of soft tissue,31 and optimally need a long T
2
 suppression element in 
the pulse sequence to reduce this problem. An advantage of the UTE sequence is its flexibility, 
which allows to filter out signals of species with extremely short T
2
* values if needed (e.g., 
background signal from coil housing).
The similar T
1
 and T
2
* values of bone and CPC preclude their discrimination by ZTE MRI 
based on relaxation properties alone. Therefore, the additions of Gd-DTPA and USPIO as MR 
contrast agents to CPC were explored. By far, the strongest effects was seen with USPIO, but 
the region occupied by the filler was heavily overestimated due to blooming effects, which 
made precise localization of the defect difficult. This is also expected to interfere with the 
proper quantitative assessment of CPC degeneration and bone regeneration by ZTE imaging. 
Another problem with USPIO addition was the detrimental effect on the solidification time 
and mechanical properties of the CPC. By lowering the iron concentration and using alternate 
types of iron oxide-based contrast agent with less susceptibility effects, it might be possible to 
minimize both the blooming problem and the detrimental effects on CPC properties and meet 
the requirements for in vivo use. For the other contrast agent tested in this study, Gd-DTPA, a 
decrease in mechanical strength and setting times at a concentration of 5% was also observed, 
57
ZTE M
RI O
F C
A
LC
IU
M
 PH
O
SPH
A
TE BO
N
E D
EFEC
T FILLER
S
3
but not at 1%. Therefore, the addition of 1 wt% Gd-DTPA to CPC was selected for testing in vivo 
and it was demonstrated that this enhanced the MR visibility of lesions repaired with CPC in the 
time immediately postoperation. The lower signal intensity reflects a shorter T
2
* of CPC. Contrast 
became less after 8 weeks; likely because of CPC degradation, resulting in loss and dilution of the 
contrast agent. This was proven by histology as will be demonstrated in a separate article.
The use of gadolinium in contrast agents is associated with the risk of nephrogenic systemic 
fibrosis.32 The commonly applied dose of Gd-DTPA in the clinic is 0.1 mmol/kg (0.2 mL/kg).33 
In this study, the amount we injected was 6 µL (in Gd-DTPA-CPC), which results in less than 
0.03 mL/kg in the rat body. Locally, Gd-DTPA in CPC will be at relatively high concentration and 
slowly released in the body.
In the future, with fine-tuning of contrast agent formulations, more optimal MR acquisition 
parameter values and suppression of long T
2
 signals are expected to further improve the 
contrast between bone and CPC. Also, the usage of iron oxide contrast at low dose is an option, 
especially if the signal intensity change can be correlated with its concentration.34 In principle 
also other MR approaches have potential to visualize repaired bone lesions like the use of 19F 
nuclei in contrast material35 or the application of 31P MR to differentiate between natural and 
synthetic hydroxyapatite.36
In conclusion, this study reported on the first in vivo MRI of a CPC repaired lesion in bone, 
using a ZTE acquisition sequence and clinically approved Gd-DTPA for enhanced contrast. This 
offers a novel radiation-free method to visualize CPC degradation and bone regeneration in 
preclinical experiments.
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aBstract
Calcium phosphate cements (CPCs) are commonly used bone substitute materials, which closely 
resemble the composition of the mineral phase of bone. However, this high similarity to natural 
bone also results in difficult discrimination from the bone tissue by common imaging modalities, 
that is, plain X-ray radiography and three-dimensional computed tomography (CT). In addition, 
new imaging techniques introduced for bone tissue visualization, like magnetic resonance 
imaging (MRI), face a similar problem. Even at high MRI resolution, the lack of contrast between 
CPCs and surrounding bone is evident. Therefore, this study aimed to evaluate the feasibility of a 
dual contrast agent, traceable with both CT and MRI as enhancers of CPC/bone tissue contrast. 
Our formulation is based on the use of silica beads as vectors, which encapsulate and carry 
contrast-enhancing nanoparticles, in our case, colloidal Gold and Superparamagnetic Iron oxide 
particles (SPIO). The bead suspension was incorporated within a calcium phosphate powder. The 
resultant cements were then tested both in vitro and in vivo in a femoral condyle defect model 
in rats. Results showed that the mechanical properties of the cement were not significantly 
affected by the inclusion of the beads. Both in vitro and in vivo data proved the homogeneous 
incorporation of the contrast within the cement and its visual localization, characterized 
by a short-term CT contrast enhancement and a long-term MR effect recognizable by the 
characteristic blooming shape. Finally, no signs of adverse tissue reactions were noticed in vivo. 
In conclusion, this study proved the feasibility of a multimodal contrast agent as an inert and 
biocompatible enhancer of CaP cement versus bone tissue contrast.
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1. introduction
The increasing incidence of bone treatment procedures keeps a high pressure on the development 
and optimization of substitutes for bone regeneration.1 Several synthetic bone substitutes are 
currently available, organic, inorganic, polymer, or ceramic-based materials. Among those, 
calcium phosphate cements (CPCs) represent a category that closely resembles the structure 
and composition of natural bone. The excellent biocompatibility of CPC and osteoconductive 
properties can be further enhanced by the introduction of structural macroporosity, for 
example, by incorporation of microparticles. The (pre)clinical application of such cements 
has been demonstrated  in vivo, for example, in a rat skull augmentation model,2  alveolar 
bone regeneration model in beagle dogs,3  maxillary sinus floor augmentation in sheep,4  and 
a critical-sized cranial defect model in rats.5  Despite their wide use and characterization, less 
achievements have been reported in the field of  in vivo visualization and follow-up methods. 
Plain radiography (X-rays) and computed tomography (CT) are the most employed techniques. 
On the other hand, recent developments in the field of magnetic resonance imaging (MRI) open 
the way to a completely new scenario of high-resolution bone visualization applications.6–8
A common problem of all imaging modalities remains the high similarity between CPCs 
and the mineral phase of the bone, which makes it difficult, if not impossible, to clearly 
discriminate the materials.9  Several opacifiers have already been proposed to enhance the 
contrast of CPCs for CT (i.e., barium sulfate, tantalum oxide) and MRI (Iron Oxide Particles, 
gadolinium).10–12  As a negative side effect, all the above-mentioned compounds have shown 
to interact with CPCs, negatively affecting both physical and mechanical properties, even at 
very low concentrations.13 Moreover, a major drawback for their in vivo application arises from 
the lack of information regarding behavior and metabolic destiny of heavy metal compounds 
following the degradation of the CPC material.14,15
In this study, we have developed a new nanocomposite that is a silica-based, dual-contrast 
agent (DCA), detectable with both CT and MRI. The specific formulation of such beads, combined 
with the chemical inertness and biocompatibility of silica, should allow the maintainance of the 
positive visualization effects of the selected contrast agents (colloidal gold and SPIO), while 
at the same time reducing unspecific reactivity, inflammatory tissue reactions, and alteration 
of the physicomechanical properties of the CPC. Colloidal gold and iron oxide nanoparticles 
were selected as embedded agents for, respectively, CT and MR imaging, as both compounds 
are widely characterized and approved for clinical use.16,17  After  in vitro  characterization, the 
developed contrast agent was tested in vivo, in a femoral condyle defect model in rats. Effects 
were monitored by scanning the same animals with both CT and MRI up to 8 weeks postsurgery. 
Finally, histology was performed to prove the biocompatibility of the product.
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2. Matherials and Methods
2.1. implant materials
CaP cement
CPC consisted of 85% of α-Tricalcium Phosphate, 10% Dicalcium Phosphate Dihydrate, and 5% 
Hydroxy Apatite. The cement powder was sterilized using gamma radiation with 25 kGy (Isotron 
B.V., Ede, The Netherlands).
PLgA microspheres
Poly (DL-Lactic-co-glycolic acid), (PURASORB; Purac, Gorinchem, The Netherlands) with a 
Lactic to Glycolic acid ratio of 50:50 and an average molecular weight of 4.55±0.03 kDa, was 
used for microparticle preparation. Acid terminated PLGA microparticles were prepared using 
a double-emulsion solvent-extraction technique. The average size of the microparticles, as 
determined with image analysis, was 20±18 µm.18 PLGA microparticles were mixed with the CaP 
cement powder in a proportion of 20%wt/wt.
Contrast agent
A customized DCA was synthetized (Nano4Imaging GmbH, Aachen, Germany). The DCA 
particles were based on an inverse emulsion approach (patent WO2005/052581) using passive 
MRI responsive SPIO nanoparticles with a mean size of 200 nm and gold nanoparticles of 
4 nm as embedded within a silica matrix at an end concentration of 40 wt/wt%. The wt% ratio 
between SPIO and gold nanoparticles was set at 4:1. The silica carrier particles containing the 
embedded iron oxide and gold nanoparticles had a mean size of 1.2 µm. They were sealed with 
an additional layer of silica synthesized using a modified Stoeber method19 and dried by dry-
freezing. The obtained solid phase of DCA particles was then mixed with the hydroxyapatite to 
reach a final end concentration of 5% (wt/wt) within the bone cement composition.
Composite preparation
The cement was created by adding a filtered sterilized (0.2-µm filter) 2% aqueous solution 
of sodium phosphate (Na
2
HPO
4
) to the PLGA/CaP or PLGA/CaP/DCA powder mixture using 
a 2-mL syringe (BD Plastipak, Becton Dickinson S.A., Madrid, Spain) with a closed tip. The 
components were shaken for 20 s using a mixing apparatus (Silamat Vivadent, Schaan, 
Liechtenstein).
CaP cement/dCA characterization
To ensure proper handling properties of the cement, the following parameters were assessed:
Gillmore test: Initial and final setting times for the different cement formulations were 
assessed using custom-available Gillmore needles (ASTM C266). A plastic mould of 3 mm 
(diameter)×6 mm (height) was used to prepare scaffolds. At least four samples from each 
formulation were mixed and injected into the mould and both initial and final setting times 
were determined. Tests were performed at room temperature.
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Compression Test: Samples were placed in a testing bench (858 MiniBionixII®; MTS, Eden 
Prairie, MN) and compressive strength in the longitudinal direction (parallel to the long axis) of 
the specimens was measured at 0.5 mm/min cross-head speed.
Morphology: The morphology of different cement formulations was determined by 
scanning electron microscopy (SEM). For this purpose, destructed samples were obtained 
from the compression test. Images from each sample were obtained at 100×, 500×, and 
1000×magnification.
2.2. In vitro assay
Bone blocks
Bone blocks of 1.5 cm3 were obtained from fresh pig bone. A 3-mm (depth and diameter) cylindrical 
defect was drilled using a dental bur and dental drills. The defects were (1) left unfilled, (2) filled 
with CaP/PLGA cement, and (3) filled with CaP/PLGA cement mixed with 5% of DCA. All samples 
were then scanned with both micro X-ray computed tomography (µCT) and MR modalities.
In vitro micro-CT
Before scanning, all specimens were dehydrated in ethanol 70% and wrapped in Parafilm® (SERVA 
Electrophoresis GmbH, Heidelberg, Germany) to prevent the occurrence of drying artifacts 
during scanning. For three-dimensional (3D) analysis, the specimens were placed vertically 
onto the sample holder of a micro-CT imaging system (Skyscan 1072, Kontich, Belgium). 
Subsequently, samples were recorded at a 14.16 µm resolution (X-ray Source 100 kV/98 µA; 
Magnification 20×; Exposure Time 3.9 s; 1 mm filter applied). Then, using NRecon V1.4 (SkyScan), 
a cone beam reconstruction was performed on the projected files. Reconstructed files were 
analyzed using CTAnalyser software (Version 1.10.1.0; SkyScan). Finally, 3D-reconstructions of 
the samples were also obtained (3D-DOCTOR 4.0, Able Software Corp., Lexington, MA).
In vitro MRI
All samples were embedded in 70% ethanol and MR imaging of bone samples was performed on 
a 11.7T MR system (Biospec, Bruker, Germany) with a mouse brain surface coil. Zero Echo Time 
(ZTE) images were acquired at 200 kHz bandwidth, TR=4 ms, flip angle=5°, FOV=50×50×50 mm, 
matrix size 128×128×128, total acquisition time 3.27 min.
2.3. In vivo assays
All in vivo work was conducted in accordance with standards and protocols of the Radboud 
University Nijmegen Medical Center, Nijmegen, The Netherlands. National guidelines for care 
and use of laboratory animals were obeyed and approval of the Experimental Animal Ethics 
Committee was obtained (RU-DEC 2010-225). Eight healthy adult male Wistar rats, weighing 
250–300 g were included as experimental animals. Surgery was performed under general 
inhalation anesthesia (Isoflurane) and aseptic conditions. For the surgical procedure (Fig. 1), 
animals were immobilized and both legs were shaved, washed, and disinfected. The knee joint 
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was exposed after a longitudinal parapatellar incision. At the femural intercondylar notch, 
a cylindrical defect (3.0 mm depth and diameter) was then prepared using a dental bur and 
continuous external cooling with saline. Defects were filled with the CPC material, or left 
untreated in control animals (Table 1), before the subcutaneous tissue and skin were closed 
by suturing in layers. In vivo CT and MRI scans were performed during time, up to 8 weeks 
postsurgery. Thereafter, animals were sacrificed and histology and micro-CT were performed.
In vivo CT
Animals were scanned after surgery and at 4 as well as 8 weeks after surgery, using a small 
animal CT scanner (Inveon; Siemens Preclinical Solutions, Knoxville, TN). Acquisitions were 
performed under general inhalation anesthesia (Isoflurane). Animals were placed in a supine 
position in the scanner and images were acquired over 6 min (spatial resolution 30 µm, 80 kV, 
500 µA, exposure time 1000 ms, frame average by 1). Projected files were then reconstructed 
using a cone beam algorithm.
In vivo MRI
MR imaging was performed the day of the surgery and at 4 as well as 8 weeks after surgery using 
a 11.7T MR system (Biospec, Bruker, Germany) with a home-built bare Helmholtz coil with a size 
Figure 1. Surgical procedure of a femoral condyle defect in rats. The knee joint was exposed after a longitudinal 
parapatellar incision (a, b). At the femural intercondylar notch, a cylindrical defect (3.0 mm depth and diameter) 
was then prepared using a dental bur and continuous external cooling with saline (c, d). Defects were filled with 
the calcium phosphate cement (CPC) material (e, f), or left untreated in control animals (Table 1), before the 
subcutaneous tissue and skin were closed by suturing in layers.
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of 3×3 cm. ZTE imaging was performed at 200 kHz bandwidth, TE/TR=0 ms/8 ms, flip angle=5°, 
FOV=50×50×50 mm, matrix size:128×128×128, four averages, and a final acquisition time of 30.27 min.
Micro-CT
Eight weeks after surgery, the animals were sacrificed by CO2/O2 overdose. Femoral condyles 
were retrieved and surrounding soft tissue was removed. Bone samples were fixed in 10% 
formalin for 48 h and subsequently transferred to 70% ethanol for the duration of the µCT scans. 
For 3D analysis, the specimens were placed vertically onto the sample holder of a micro-CT 
imaging system (Skyscan 1072). Subsequently, samples were recorded at a 15.30 µm resolution 
(X-ray Source 100 kV/98 µA; Exposure Time 3.9 s; 1 mm filter applied). Then, using NRecon 
V1.4 (SkyScan), a cone beam reconstruction was performed on the projected files. Finally, 3D 
reconstructions of the samples were obtained (3D-DOCTOR 4.0; Able Software Corp.).
Histology
After scanning, all specimens were decalcified in 5% formic acid at 37°C for 5 days with a daily 
solution replacement. Samples were then dehydrated in gradual series of ethanol (70%–100%) 
and embedded in paraffin. Sections of 6 µm thickness were cut in a plane parallel to the long axis 
of the femur using a Leica RM2165 Microtome (Leica Microsystems, Rijswijk, The Netherlands). 
The sections were stained with Hematoxylin/Eosin and trichrome Elastin van Gieson (EVG); at 
least three sections of each specimen were analyzed.
Bone quantification
EVG-stained slides were quantitatively scored using computer-based image analysis techniques 
(Leica Qwin Pro-image; Leica, Wetzlar, Germany). From digitalized images (magnification 5×), 
the percentage of bone tissue was determined within the area of interest, positioned between 
the growth plates, and the cortical bone layer.
Table 1. Experimental Groups and Implantation Scheme.CPC, calcium phosphate cement; DCA, dual contrast agent.
Table 1. Experimental groups and implantation scheme
Rat Left Right
1 No defect Empty defect
2 Empty defect CPC
3 CPC CPC/DCA
4 CPC/DCA No defect
5 No defect Empty defect
6 Empty defect CPC
7 CPC CPC/DCA
8 CPC/DCA No defect
67
D
U
A
L C
O
N
TR
A
ST A
G
EN
T FO
R BO
N
E IM
A
G
IN
G
4
Statistical analysis
Statistical analysis for bone quantification was performed using SPSS, version 16.0 (SPSS, Inc., 
Chicago, IL). Statistical comparisons were performed by one-way analysis of variance (ANOVA) 
with a Tukey’s multiple comparison post-test. For setting time and compression tests, data 
are presented as mean±standard deviation and significant differences were determined by 
ANOVA. Gray values distributions were validated by the Wilcoxon matched-pairs signed-ranks 
test. Calculations were performed using GraphPad Instat® (GraphPad Software, San Diego, CA). 
All differences were considered significant at p-values<0.05.
3. results
3.1. initial observations
After freeze-drying, increasing concentrations of DCA, ranging from 1 to 10% (wt/wt%) were 
incorporated within the CaP/PLGA powder. The lowest concentration required for imaging was 
reached at 5%. At higher concentrations, the physicomechanical properties of the material 
were altered. Consequently, 5% was maintained throughout (data not shown).
3.2. caP cement/dca characterization
To exclude eventual interactions between the DCA and CaP/PLGA matrix, physicomechanical as 
well as morphological tests were performed. Figure 2a shows the initial and final setting times 
of the two cements, with and without DCA. The Gillmore test showed no significant differences 
between the two groups. Initial setting time required around 9 min, while for the final setting 
time, 21–22 min were needed. The contrast was uniformly mixed with the cement powder, 
providing a uniform light brown color.
Measurements of the peak load (compression strength) and E-Modulus for CPC, with and 
without a contrast agent, are presented in Figure 2b and 2c, respectively. Both parameters appear 
slightly altered by the incorporation of the contrast agent, namely, the strength of the resulting 
material is increased, even though the difference cannot be considered statistically significant.
From the morphological point-of-view, Figure 3 shows representative scanning electron 
micrographs of CPC and CPC plus the DCA. In both samples, PLGA particles were easily 
recognizable, dispersed evenly in the Calcium Phosphate matrix. The overall structure appeared 
uniform between the samples and the presence of the contrast agent did not affect the internal 
structure of the cement upon visual inspection.
3.3. In vitro assays
At visual inspection, no differences emerged during both preparation and injection of the 
cements, with and without 5% wt/wt contrast, into the premade bone blocks. After final setting, 
all samples were scanned with both MRI and µCT.
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Figure 2. Mechanical properties of CPC versus CPC/dual contrast agent (DCA). (a) Gillmore test for initial and final 
setting time measurements.; for both composites, initial setting time required 8–9 min, while for the final setting 
time 21–22 min was required, (b, c) respectively, show E-Modulus and Peak Load as measures of the mechanical 
strength of the two materials. All data are showed as mean value±standard deviation.
Magnetic resonance imaging
After mixing with the DCA, the cement was immediately injected to fill the defects created into 
the cortical layer of the bone blocks (Fig. 4a).
While the untreated defect was easily identifiable in the upper part of the specimen, within 
the cortical layer (Fig. 4b), in case of defect filled with plain CPC, the visual inspection did not 
allow localization of the defect area within the surrounding cortical bone (Fig. 4d).
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Figure 3. Scanning electron micrographs. (a) CPC containing PLGA microsphere at 500× and 1000× magnification; (b) 
CPC containing PLGA microspheres and DCA at 500 ×and 1000× magnification. Arrows indicate PLGA microspheres.
When the DCA was added to the cement, the presence of SPIO particles made the defect 
easily identifiable as well as characterized by the presence of an artifact known as the blooming 
effect (result of the dipolar behavior of the iron particles). Although the defect area was easy 
to localize, the blooming artifact caused an overestimation of the defect size, complicating 
possible quantification methods (Fig. 4e).
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Figure 4. In vitro magnetic resonance imaging (MRI). (a) A 5 mL syringe filled with CPC/DCA composite used 
to fill a bone defect created in the cortical part of 1.5 cm3 bone blocks (b), which reveals the brownish color of 
the CPC. The following images are representative slides from the acquired three-dimensional (3D) dataset of 
the bone blocks with: (c) empty defect; (d) defect filled with plain CPC; (e) defect filled with CPC/DCA cement. 
The evident blooming effect caused by the presence of the contrast is recognizable. The bone samples were 
embedded in 70% ethanol. Red arrows indicate the location of the defects.
Computed tomography
Based on the images, it was already possible to visually identify a clear difference between plain 
CPC and CPC with the DCA. Plain CPC could not be discerned from the surrounding cortical 
bone (Fig. 5a), while with the contrast (Fig. 5b), the difference between the material and bone 
was evident. Figure 5c shows the unfilled defect as control. The contrast agent was distributed 
evenly through the cement matrix. Quantitatively, the analysis of gray values revealed two 
different curves for CPC and CPC/DCA. The curve generated from the empty defect is also 
included. As shown in Figure 5d, plain CPC gave a distribution peak corresponding to gray 
values of 100–120. The incorporation of the DCA caused a shift of the population to the left part 
of the scale, toward gray values ranging from 80 to 90. No peak was found in the empty defect.
3.4. In vivo
Animal model
The surgical procedure (Fig. 1) did not lead to any adverse and unexpected reactions. All animals 
recovered within a few hours postsurgery and none were restricted in their movements. Rats were 
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monitored during the whole experimental period and no evident signs of discomfort or weight 
loss were observed. Based on in vitro explorative data, the concentration of the DCA to be mixed 
with the cement powder was set at 5% wt/wt. After 8 weeks, all femoral condyles were retrieved; 
at macroscopical inspection, no clear differences were detectable between the different groups.
Magnetic resonance imaging
In line with in vitro results, injected plain CPC were not detectable in the femoral condyles at 
any time point and the resulting images were comparable to those obtained from untreated 
femoral condyles’ defects. In contrast, the visibility of the CPC was enhanced by the presence 
of DCA (Fig. 6) at all evaluation times. The addition of DCA caused a similar blooming effect as 
in the in vitro assay. However, it was observed that visibility and contrast clearly decreased with 
the increasing implantation time.
Computed tomography
Figure 7 shows that, in agreement with in vitro data, no differences in terms of gray values were 
measured between plain CPC and surrounding bone tissue at any evaluation time. However, the 
incorporation of the DCA provided a significant enhancement of the radiopacity, resulting in a 
good contrast between the bright CPC-treated defect and the surrounding tissues. Moreover, bone 
healing was observed within the untreated defect within the 8 weeks evaluation. Distributions of 
gray value in Figure 7b highlighted a shift of the population from gray values of 100–120 for plain 
CPC, to values ranging from 80 to 90 when DCA was incorporated. This effect was only detectable 
at the first time point, while 8 weeks post-surgery, the gray value distributions for the two cements 
were mostly overlapping (Fig. 7c). Gray values from untreated defects are always shown as control.
Figure 5. In vitro computed tomography (CT). 2D (left panel) and 3D (right panel) µCT images of (a) plain CPC; (b) 
CPC/DCA cement injected into 3-mm defects in pig bone blocks; (c) Untreated empty defect. CPC/PLGA filling 
becomes clearly identifiable after incorporation of the DCA (in red in the µCT model of the whole bone block). 
(d) Gray values curve distributions for the two composite materials and the empty defect. The shift of the DCA 
population toward the left side of the graph is significant with p<0.05.
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Histology and bone quantification
In none of the histological sections an adverse tissue reaction or signs of inflammation were 
found (Fig. 8). Both HE and EVG staining showed a uniform bone reaction in all groups. Due to 
decalcification of the specimens before paraffin embedding, the CPC no longer was detectable 
within the stained sections. Still, a round-shaped area could be recognized, which was used 
to localize the original defect site within the condyle. Upon light microscopical inspection, 
all defect areas appeared to be filled by the newly formed trabecular bone. Bone marrow-like 
Figure 6. In vivo MRI. Representative slides selected from 3D-acquired datasets of rat femoral condyle defects 
filled with plain CPC (first column), CPC/DCA cement (second column), or empty untreated defects (third 
column) acquired by Zero Echo Time sequence at day 0, 4 weeks and 8 weeks following cement installation. 
Arrows indicate the location of the defect.
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tissue was observed in between the bone voids and the fibrotic tissue was absent. The defect 
location, between the cortical bone layer and the growth plates, was selected to quantify the 
bone tissue percentage (Fig. 9a). Eight weeks after implantation, results from the 4 experimental 
groups did not reveal statistically significant differences in the bone content, which was found 
to be around 50% in the selected area in all groups (Fig. 9b).
4. discussion
The present study aimed to test the feasibility of a DCA as an enhancer for the visualization of 
CPC in terms of bone contrast using CT and MR imaging. Both in vitro and in vivo assays were 
done. The DCA, as used, was a nanocomposite of silica beads in which two different nanoparticle 
types are structurally integrated. For our study, colloidal gold and superparamagnetic iron oxide 
nanoparticles were incorporated. The gold/iron ratio content per bead is predetermined by 
the detection equipment and knowledge of the individual (not dual) products already applied 
clinically. Following explorative pilot experiments with scans at different DCA in gradual steps 
from 1%–10%, it was shown that below 4% no quantifiable CT contrast was obtainable. Data 
also show that the higher ranges result in improper cement hardening, which is hampered. 
Thus, the final concentration within our cement was set at 5% wt/wt. Mixing of the two 
components was homogeneous conferring a uniform brown color to the cement, and indeed 
the cement’s preparation and injection procedure did not differ from control groups. Setting 
Figure 7. In vivo CT. (a) 2D-CT images of rat femoral condyle defects filled with plain CPC, CPC/DCA cement, 
or empty untreated defects. Upper images were taken immediately after implantation, while bottom images 
were taken 8 weeks postimplantation. Red arrows indicate the defect. (b) Gray values curve distributions of 
the two composite materials at day 0. The shift of the DCA population toward the left side of the graph was 
considered significant with p<0.05. (c) 8 weeks postsurgery, the differences between the two curves were no 
longer significant. Gray value curves from untreated defects are also shown as control.
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time and compressive strength are of great interest to surgeons, as these data directly affect 
the selection of the operation procedure and postoperative care. The presence of DCA did not 
induce significant changes of those parameters, or even account for a slight enhancement of 
the mechanical strength. Thus, the handling remained acceptable within a defined range.15,20
The applied rat model is a well-established noncritical size femoral condyle defect to 
testing injectable as well as preset bone substitute materials.21,22 The relatively uncomplicated 
surgical procedure, together with the easily accessible location for imaging procedures, makes 
this model optimal for the purposes of our study. Postimplantation imaging was evident in 
both techniques, which could be of great benefit to surgeons to verify proper implant placing 
Figure 8. Qualitative histological evaluation. Elastin van Gieson representative histological sections after 8 weeks 
of implantation. (a) Empty defect; (b) CPC-filled defect; (c) Sham-operated, no defect was created; (d) CPC/
DCA- filled defect. A black dashed circle indicates the location of the defect. After decalcification of the samples, 
no traces of CPC remained visible.
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directly postoperatively. Long-term contrast enhancement was only achievable by MRI, which 
signal decay over the experimental period could be assessed, thus aiding quantification of the 
biomaterial degradation process.
At 8 weeks after injection, CPC/DCA implants were still detectable by MRI, while CT contrast 
had become negligible. This indicates that also temporal degradation of the nanocomposite 
occurs and could allow kinetic studies with the DCA, since the contrast disappears during 
remodeling of the cement. The disappearance of the CT signal with time could be explained 
as a result of the degradation of the outer shell of the silica beads,23,24 resulting in dilution of 
the gold nanoparticles. Instead, iron nanoparticles were placed on the inside of the bead, 
which degrade much slower. Although the location of the two embedded agents (either in the 
core or in the shell) does not affect directly the imaging properties of the DCA, results proved 
that it could become a valuable parameter when performing longitudinal studies, where a 
long-lasting contrast is needed. Finally, histological sections and histomorphometry proved 
biocompatibility and no interference of the contrast agent with the healing rate and bone 
ingrowth compared to plain CPC and control groups. As shown in Figure 8, the whole defect 
area was not located within the selected region of interest. However, the goal of the study was 
to test the influence of the DCA on bone growth rate and quality compared with plain CPC. 
Therefore, as following decalcification procedures CPC was degraded and impossible to be 
accurately localized, we still assume defining a well-delimited area the most accurate method. 
Here, the influence of the defect on bone quantity could be considered constant between all 
samples. Still, information regarding osteoinductive performance and degradation of CPC/
DCA were precluded by the dissolution of the cement and will require further investigation.
µCT is often employed to evaluate the outcome of bone regeneration studies, as it provides 
qualitative as well as quantitative information based on differences in gray values between 
different tissues. However, visualization of CPC is still challenging and several radiopacifying 
Figure 9. Quantitative evaluation of bone formation. (a) Bone formation was measured within the yellow 
highlighted region of interest in the four experimental groups, 8 weeks after implantation. (b) Bone percentage 
in all groups was around 50%, without statistically significant differences (p>0.05).
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materials are currently employed (bismuth, strontium, barium, colloidal gold, a.o.).25 In a recent 
study by Camilleri and Gandolfi,26 an adequate radiopacity was achieved with the use of 30% zinc 
oxide and similar results were obtained by the group of Húngaro Duarte27 with zirconium oxide. 
However, very high concentrations of the embedded material will always (negatively) influence 
the handling properties of cement in terms of setting time and mechanical outcome. A strategy 
to decrease the concentration of a contrast agent to avoid interferences with physicomechanical 
performances of the cement28 is to choose high atomic number compounds.11 In the study of 
Aguilar et al.,25 bismuth oxide showed good contrast enhancing properties at a concentration 
of 20%, while choosing an even higher atomic mass compound as nanometric particulate of 
tantalum oxide, Hoekstra et al.29 were able to decrease the concentration up to 10% wt/wt. Still, 
the problem arising from the use of such heavy metal compounds, besides unspecific reactivity, 
is the lack of information about their metabolic destiny, possible accumulation, and toxicity 
after being released after CPC degradation.16,17,30,31 In the current study, the concentration of both 
radiopacifiers was set at 5% wt/wt. The structural embedding of two nanoparticles types into 
the silica carrier beads prevents/inhibits their release as free metal ions, and allows even the 
encapsulation of much higher concentrations, while avoiding the above mentioned side effects. 
The advantage is that after dissolution of the organic silica matrix, the inert nanoparticles can be 
cleared through intestinal macrophages and renal filtration.32,33
As a second approach, MR Imaging was selected as means of visualization. MRI is the gold 
standard for soft tissue imaging, such as breast and prostate, but has recently started to be 
exploited for hard tissue applications too. The development of short Echo Time acquisition 
sequences, like Ultra Short Echo Time and ZTE,8–10,34 opened the way to new possibilities for 
bone-related applications.
In a recent study, Sun et al.35 aimed to evaluate the feasibility of ZTE acquisition for CPC 
visualization. Gd-DTPA (Magnevist®) and USPIO (Sinerem®) were used as in vitro and in vivo 
enhancers of CPC contrast. Despite the positive results in terms of contrast enhancement, 
both compounds negatively affected the physical and mechanical properties of CPC, even at 
concentrations as low as 1% wt/wt. This precludes their further clinical application. The herein 
proposed Dual Contrast approach allows, by encapsulation and isolation of the contrast agents, 
to prevent unspecific reactivity. The CT acquisition could be directly translated into clinical 
applications; however, MR bone imaging is still undergoing developmental and optimization 
steps at a preclinical level. Although ZTE acquisition represents a valuable tool for hard tissue 
imaging, the integration within clinical instruments is still an ongoing process as first specific 
instrumental as well as software requirements must be fulfilled.
In the present study, SPIO particles and colloidal gold nanoparticles were jointly 
encapsulated into the silica beads. Although gadolinium-chelates36,37 have been described 
earlier, SPIO currently appear to be preferred as MRI contrast agents. Such particle labeling is 
considered favorable because: (1) SPIO account for the highest change in signal per unit of metal, 
in particular, on T
2
*-weighted images. Since SPIO are composed of thousands of iron atoms, 
they defeat the inherent low-contrast agent sensitivity of MRI; (2) SPIO are biocompatible and 
biodegradable and can be reused/recycled by cells using normal biochemical pathways for iron 
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metabolism; (3) SPIO can be magnetically manipulated, while their magnetic properties differ 
according to size, as well as their structural conformation (e.g., free vs. bound state).38
Gold nanoparticles have been shown to be superior compared to several other radiopacifiers 
(e.g., Iodinated compounds). The application of Gold results in higher absorption with less 
bone and tissue interference achieving better contrast with lower X-ray dose.39 In fact, imaging 
gold at 80–100 keV reduces interference from bone absorption and takes advantage of lower 
soft tissue absorption helping to reduce patient radiation doses.40
The encapsulation of both compounds into a silica matrix appeared to be a good strategy 
to prevent side reactions between CPC and contrast agents. A major drawback of iron oxide 
particles as an MR-T
2
* contrast enhancer is the resulting so-called blooming effect, often 
caused by overload or simple clustering of iron oxide particles within the tissue.41
Possible strategies to reduce the blooming effect are suggested by recent studies and 
consist in reducing the concentration of nanoparticles, in the tuning and modification of the 
MR acquisition parameters,42,43 or incorporation of MR contrast agents, like gadolinium or 
fluorine. Moreover, MRI contrast agents are usually employed in Gradient Echo scans at 1.5 Tesla 
in which blooming effects are less evident. Despite, what needs to be taken in consideration is 
that the effect of the contrast agents also strongly depends on the MRI technique employed. 
In our case, in contrast with Gradient Echo techniques, with the ZTE, the affected signal is not 
lost, but blurred as well as dislocated, contributing to a further signal intensity increase. The 
localization of our CPC/DCA resulted, therefore, more obvious, but at the same time, a direct 
signal quantification was hampered. Still, recent literature has already shown that quantification 
of the iron particle-signal is possible by means of novel susceptibility mapping techniques in 
combination with relaxation time mapping techniques. However, these methods have to be 
developed further, as only preliminary studies are currently reported.44,45
The hereby presented formulation allowed the clear verification of proper implant placing 
with both methods. The long-term contrast enhancement provided by MRI opens longitudinal 
quantification possibilities. The contrast degradation, proved by disappearance of CT contrast 
enhancement, suggested that degradation analyses would also be possible and tailoring 
degradation and contrast persistance is a way that will be surely explored in future studies.
Furthermore, due to the inhert behavior of the carrier, we assume that the DCA could be 
incorporated within virtually any kind of material, that is, different ceramic or polymer-based 
materials. Finally, we envision that besides contrast-enhancing agents, the hereby proposed 
bead-carrier can ideally also be employed for the incapsulation of different molecules (i.e., 
bioactive molecules, drugs, growth factors, etc.) for regenerative medicine applications. In 
conclusion, the combination of two different contrast agents within one silica bead carrier 
product allows to obtain complementary information from multiple imaging modalities, 
without changing the overall biomaterial performance in calcium phosphate ceramic.
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aBstract
With biomimetic biomaterials, like calcium phosphate cements (CPCs), non-invasive assessment of 
tissue regeneration is challenging. This study describes a theranostic agent (TA) to simultaneously 
enhance both imaging and osteogenic properties of such a bone substitute material. For this 
purpose, mesoporous silica beads were produced containing an iron oxide core to enhance bone 
magnetic resonance (MR) contrast. The same beads were functionalized with silane linkers to 
immobilize the osteoinductive protein BMP-2, and finally received a calcium phosphate coating, 
before being embedded in the CPC. Both in vitro and in vivo tests were performed. In vitro testing 
showed that the TA beads did not interfere with essential material properties like cement setting. 
Furthermore, bioactive BMP-2 could be efficiently released from the carrier-beads. In vivo testing 
in a femoral condyle defect rat model showed long-term MR contrast enhancement, as well as 
improved osteogenic capacity. Moreover, the TA was released during CPC degradation and was 
not incorporated into the newly formed bone. In conclusion, the described TA was shown to be 
suitable for longitudinal material degradation and bone healing studies.
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1. introduction
The growing need for bone treatment procedures keeps a high pressure on the development 
and optimization of artificial substitutes for bone regeneration. Calcium phosphate (CaP) 
based materials are amongst the most commonly used, as they closely resembles structure 
and composition of the natural bone. Especially, injectable CaP-based cements (CPCs) have 
the advantage of optimal bone defect filling capacity, and are applicable through minimally 
invasive surgery [1]. The osteoinductivity of such materials can be enhanced by incorporating 
biologically active molecules, like BMP-2, either via adsorption onto pre-set CPC scaffolds [2], 
or via loading before the CPC setting.
At the same time, assessment of tissue regeneration is essential to optimize the stages of 
bone healing. Most commonly, bone healing is assessed with X-ray or computed tomography 
(CT) assessments. Recently, also zero echo time (ZTE) magnetic resonance imaging (MRI) [3], 
has proved to be a powerful tool for bone tissue imaging. However, all commonly used 
techniques for bone imaging lack sensitivity to detect the presence of synthetic bone 
substitutes, without additional contrast enhancement. Advances in the fields of material 
science, imaging and formulation development lead to the development of theranostics, which 
aims at combining both therapeutic (e.g. the BMP-2) and diagnostic (e.g. the MR detection) 
functions within a single product. Theranostic medicine is currently explored to enhance 
the quality of cancer treatments, atherosclerosis, infections, and a variety of regenerative 
medicine applications [4]. In this study, we have developed a theranostic agent (TA), a silica-
based nanocomposite MR contrast agent, which also functions as carrier for BMP-2 release. 
The specific formulation of such a composite, combined with the biocompatibility of silica, 
is meant to provide imaging contrast enhancement, while reducing unspecific reactivity and 
improving the osteogenic performance of CPCs. After in vitro characterization, the developed 
TA was tested  in  vivo, in a femoral condyle defect model in rats. Imaging properties were 
monitored by MRI, while osteogenic performance was measured by histomorphometry, up to 
8 weeks post-implantation.
2. Materials and Methods
2.1. caP cement with Plga microspheres
Calcium phosphate cement consisted of 85% of α-tricalcium phosphate, 10% dicalcium 
phosphate dihydrate and 5% hydroxyapatite [5]. The cement powder was sterilized using gamma 
radiation with 25 kGy (Isotron B.V., Ede, The Netherlands). As a porogen, acid-terminated PLGA 
microparticles were prepared using a double-emulsion solvent-extraction technique. Poly 
(dl-lactic-co-glycolic acid), (PURASORB, Purac, Gorinchem, The Netherlands) with a lactic to 
glycolic acid ratio of 50:50 and an average molecular weight of 4.55 ± 0.03 kDa, was used for 
microparticle preparation. The average size of the microparticles, as determined with image 
analysis, was 96 ± 16 µm [6]. PLGA microparticles were mixed with the CaP cement powder in a 
proportion of 20% wt/wt.
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2.2. theranostic agent
A customized theranostic agent (TA) was synthesized. The contrast agent particles were 
prepared by an inverse emulsion approach (patent WO2005/052581; Nano4Imaging GmbH, 
Aachen, Germany) using MRI responsive ultra small iron particles (USPIO) embedded within a 
mesoporous silica matrix. Two contrast agent formulations were tested: (i) MRI-1 with an iron 
oxide core size range of 200–300 nm at an end concentration of 40% wt/wt, and (ii) MRI-2 with 
an iron oxide core size range between 0.5 and 1.2 µm at an end concentration of 30% wt/wt.
BMP-2 (Pfizer, InductOs® former Wyeth Europe Ltd., Berkshire, UK) was immobilized onto the 
surface of the beads, functionalized with silane linkers carrying amino functions (3-aminopropyl-
trimethoxysilane), as described by Elhert et  al.  [7]. A solution containing 10  µg of BMP-2 was 
mixed with a suspension of beads (12.5  µL at a concentration of 20  mg/mL) in phosphate-
buffered saline (PBS) buffer (pH 6.8). PBS was then removed and the beads were resuspended in 
50 mm 2-(N-morpholino) ethanesulfonic acid (MES) buffer (pH 5.5) and placed at 4 °C, overnight.
Finally, the TA beads were given a calcium phosphate coating. For this, 500 µL of a 5 mg/mL 
contrast agent suspension, containing 10 µg of BMP-2, was mixed with 54 µL of 40 mm CaCl
2
, 
77 µL of 3.9 mm Na
2
HPO
4
and 60 µL of 1 mm NH
3
. The mixture was placed at 4 °C for 1 h. After pH 
had reached 7.9, 60 µL of 1 mm NH
3
was added into the solution, and again placed at 4 °C for 1 h. 
When pH was 8.5, again 80 µL 1 mm NH
3
 was added and the solution remained at 4 °C for 1.5 h. 
The final pH was 9.5. The suspension was maintained under continuous rotation throughout the 
entire procedure. The resulting coated beads were magnetically separated and washed 4 times 
in PBS. The precipitate was then diluted to an end concentration of 20 mg/mL. Control samples 
were treated the same way, with exception that the beads did not contain BMP-2. After freeze-
drying, the obtained solid phase was then mixed to reach a final end concentration of 0.1% (wt/
wt) within the bone cement/PLGA composite.
2.3. composite preparation
The cement was created by adding a filtered sterilized (0.2  µm filter) 2% aqueous solution of 
sodium phosphate (Na
2
HPO
4
) to the PLGA/CaP or PLGA/CaP/TA powder mixture using a 2-mL 
syringe (BD Plastipak, Becton Dickinson S.A., Madrid, Spain) with a closed tip. The components 
were shaken for 20 s using a mixing apparatus (Silamat Vivadent, Schaan, Liechtenstein).
2.4. characterization of cPc and ta
2.4.1. Theranostic agent-beads
The morphology of the TA beads was determined by SEM and transmission electron microscopy 
(TEM). SEM images were obtained at 2000×, 5000× and 10,000× magnification, while TEM 
images were obtained at 30K and 50K.
Elemental analysis was performed using a scanning electron microscope (SEM, Philips 
XL30, Eindhoven, The Netherlands) coupled with an energy dispersive X-ray spectrometer 
(EDS, EDAX, AMETEK Materials Analysis Division, Mahwah, NJ). Samples were sputtered with 
a thin layer of gold using a common sputtering instrument (Cressington 108A, Watford, UK) to 
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improve the surface conductivity. The EDS elemental maps were taken at accelerating voltage 
of 15 KeV and working distance of 10 mm.
2.4.2. CPC
Initial and final setting times for the different cement formulations were assessed using custom 
available Gillmore needles (ASTM C266). A plastic mould of 3 mm (diameter) × 6 mm (height) 
was used to prepare the scaffolds. Both initial and final setting times were determined and tests 
were performed at room temperature. Thereafter, for mechanical testing samples were placed 
on an 858 MiniBionixII® testing bench (MTS, Eden Prairie, MN) and the compressive strength in 
the longitudinal direction of the specimens was measured at 0.5 mm/min cross-head speed. 
Finally, to assess morphology all different cement formulations were assessed by scanning 
electron microscopy (SEM). For this purpose, destructed samples were obtained from the 
compression test. Images were obtained at 500×, 1000× and 2000× magnification.
2.5. Ex vivo Mri
Sixteen explanted rat femoral condyles were collected, which were left-over material from 
unrelated experiments (RU-DEC 2012-317). In each condyle, a cylindrical defect was made of 
3.0 mm depth and diameter; and filled bearing either the contrast agent MRI-1 or MRI-2 mixed 
into the CPC, at a concentration of both 0.1 and 0.5% wt/wt (n = 4 for each condition). After 
30  min, condyles were immersed in 70% ethanol and MR imaging was performed on a 11.7T 
MR system (Biospec, Bruker, Germany) with a mouse brain surface coil. Zero echo time (ZTE) 
images were acquired for all samples at the same time and settings, to avoid confounding 
effects of individual calibration or thresholding, at 200 kHz bandwidth, TR = 4 ms, flip angle = 5°, 
FOV = 50 × 50 × 50 mm, matrix size 128 × 128 × 128, total acquisition time 3.27 min.
2.6. BMP-2 immobilization and release
Following BMP-2 immobilization, the amount of BMP-2 effectively bound to the surface of 
the beads was measured. Thereafter, BMP-2 release tests were performed and the protein 
concentration was measured by both ELISA, to quantify all released BMP-2, and BRE-Luc assay, 
to specifically quantify the fraction of bioactive BMP-2.
2.6.1. Quantification of effectively bound BMP-2
The fraction of BMP-2 bound to the silica beads was determined by enzyme-linked immunosorbent 
assay ELISA assays, with a Quantikine® BMP-2 immunoassay kit (R&D Systems, Minneapolis, MN) 
following the manufacturer’s instructions. The assay was performed for all process steps, i.e. (i) on 
the MES buffer used for the immobilization, and removed during the first washing step, (ii) on the 
PBS collected after the following washing steps, and finally (iii) on the resulting beads.
2.6.2. Quantification of released BMP-2
A 12.5  µL aliquot of the bead suspensions, loaded with BMP-2 was resuspended in 500  µL of 
minimum essential medium alpha (MEM-α). Both coated and non-coated samples remained in 
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the medium for 2 h, 3 days and 7 days. The amount of BMP-2 released into the supernatants was 
determined using ELISA (R&D Systems) and BRE-Luc assay, described below.
2.6.3. BRE-Luc assay
M3T3-BRE-Luc cells were cultured in Dulbecco’s modified eagle’s medium (DMEM) containing 
5% fetal bovine serum (FBS) and 800 µg/mL neomycine, at 37 °C in a humidified atmosphere of 
5% CO
2
. Cells were trypsinized and seeded at a concentration of 2 × 104 in 100 µL of 5% FCS-DMEM 
in a flatbottomed transparent plate for 24 h. After removing the culture medium, 100 µL of the 
samples medium, containing the released BMP-2, were added into the wells, together with 2% 
FBS. To estimate BMP-2 release, a standard curve obtained with soluble BMP-2 in dilutions from 
0.4 until 50 ng/mL (100  µL/well) was performed in parallel. Following the incubation time of 
16–20  h, the medium was removed and replaced by 25  µL of reporter lysis buffer (Promega, 
Madison, WI). The incubation was done at −80 °C for at least 1 h. After defrosting, 25 µL of Bright 
glow (Promega) were added to each well and the luciferase intensity was measured (LUMIstar 
Omega, BMG LABTECH GmbH, Ortenberg, Germany).
2.7. In vivo assays
2.7.1. Animal model
All  in  vivo  work was conducted in accordance with standards and protocols of the Radboud 
University Medical Center, Nijmegen, The Netherlands. National guidelines for care and use of 
laboratory animals were obeyed and approval of the Experimental Animal Ethical Committee 
was obtained (RU-DEC 2012-060). Ten healthy adult male Wistar rats, weighing 250–300 g were 
included as experimental animals. Surgery was performed under general inhalation anesthesia 
(Isoflurane) and aseptic conditions. For the surgical procedure animals were immobilized and 
both legs were shaved, washed and disinfected. The knee joint was exposed after a longitudinal 
parapatellar incision. At the femoral intercondylar notch, a cylindrical defect (3.0  mm depth 
and diameter) was then prepared using a dental bur and continuous external cooling with 
saline. Defects were filled with the various CPC materials, or left untreated in control animals 
(Table 1), before the subcutaneous tissue and skin were closed by suturing in layers. In vivo MR 
scans were performed 4 and 8 weeks post-surgery. Thereafter, animals were sacrificed and 
histology and micro-CT were performed.
2.7.2. In vivo MRI
MR imaging was performed 4 and 8 weeks after surgery using a 11.7T MR system (Biospec, Bruker, 
Germany) with a home-built bare Helmholtz coil with a size of 3 × 3 cm. Zero echo time imaging 
was performed at 200 kHz bandwidth, TE/TR = 0 ms/8 ms, flip angle = 5°, FOV = 50 × 50 × 50 mm, 
matrix size: 128 × 128 × 128, 4 averages and a final acquisition time of 30.27 min.
2.8. Micro-ct
Eight weeks after surgery, the animals were sacrificed by CO
2
/O
2
 overdose. Femoral condyles were 
retrieved and surrounding soft tissue was removed. Bone samples were fixed in 10% formalin for 48 h 
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and subsequently transferred to 70% ethanol for the duration of the µCT scans. For 3D analysis, the 
specimens were placed vertically onto the sample holder of a micro-CT imaging system (Skyscan 
1072, Kontich, Belgium). Subsequently, samples were recorded at a 11.10 µm resolution (X-ray source 
100 kV/98 µA; Exposure time 3.9 s; 1 mm filter applied). Then, using NRecon V1.4 (SkyScan), a cone 
beam reconstruction was performed on the projected files. Finally, 3D-reconstructions of the 
samples were obtained (3D-DOCTOR 4.0, Able Software Corp, Lexington, MA).
2.9. histology
After scanning, all specimens were decalcified for 72 h in 10% ETDA. Samples were then dehydrated 
in gradual series of ethanol (70%–100%) and embedded in Paraffin. Sections of 6  µm thickness 
were cut in a plane parallel to the long axis of the femur using a Leica RM2165 Microtome (Leica 
Microsystems, Rijswijk, The Netherlands). The sections were stained with haematoxylin/eosin and 
trichrome Elastin van Gieson (EVG); at least six sections of each specimen were analyzed.
2.10. Bone quantification
The EVG-stained slides were quantitatively assessed using computer-based image analysis 
techniques (Leica Qwin Pro-image, Leica, Wetzlar, Germany). From digitalized images 
(magnification 2.5×), the percentage of bone tissue was determined within the area of interest, 
positioned accordingly to the original size and position of the created defect.
2.11. statistical analysis
Statistical analysis for bone quantification was performed using GraphPad Instat®  (GraphPad 
Software, San Diego, CA). Statistical comparisons were performed by one-way analysis of 
variance with a Tukey multiple comparison post-test. For setting time and compression tests, 
Table 1. Experimental groups and implantation scheme. With the aim of testing both the MR contrast agent and 
BMP-2 performance, four experimental groups were selected: (i) Empty – untreated defect, (ii) CPC – defect 
filled with injectable calcium CPC, (iii) MRI – defect filled with injectable CPC incorporating the MR contrast 
agent and (iv) MRI/BMP2 – defect filled with injectable CPC incorporating the MR contrast agent and BMP-2.
Rat Right defect Left defect
1 Empty CPC
2 CPC MRI
3 MRI MRI/BMP2
4 MRI/BMP2 Empty
5 Empty CPC
6 CPC MRI
7 MRI MRI/BMP2
8 MRI/BMP2 Empty
9 Empty CPC
10 MRI/BMP2 MRI
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data are presented as mean ± standard deviation and significant differences were determined 
by analysis of variance (ANOVA). All differences were considered significant at P-values <0.05.
3. results
3.1. characterization of ta beads
As evident from the SEM micrographies, the beads presented a uniform size distribution 
(Fig. 1a), with a mean value of 1.68 ± 0.86 for MRI-1 and 1.65 ± 0.78 µm for MRI-2. From the TEM 
image it was possible to identify the inner iron core which appears darker, as more electron 
dense, surrounded by the silica matrix (Fig.  1b). As shown in  Fig.  1c, five principal elements 
could be detected: silicon (Si) and oxygen (O) as components of the silica matrix, phosphorus 
(P) and calcium (Ca) from the most superficial coating layer, and iron (Fe) from the inner core. 
The spatial distribution of Fe, O and Si was homogeneous throughout the entire field of view, 
delimited by the SEM micrography. Differently, despite being well-distributed throughout the 
whole sample, presence of Ca and P showed evident variability even within the single beads.
Fig.ure 1. Morphological characterization of the TA beads. a. SEM micrograph of the TA particles at 1000× 
magnification; b. TEM image of a single TA particle before CaP coating, at a magnification of 50K. The more 
electron dense inner iron core appears darker, while the surrounding silica matrix appears lighter. c. Elemental 
analysis of the final TA performed using SEM coupled with an EDS. Spatial distribution maps and relative 
abundance of the single elements are herein presented as atomic percentage. The upper right image shows the 
overlap of all detected elements.
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3.2. characterization of cPc/ta
All formulations showed a uniformly distributed appearance of the TA within the cement powder 
(Fig. 2a). At both the 0.1 and 0.5% wt/wt concentrations, no differences were measured in initial or 
final setting time with the incorporation of MRI-1. The addition of MRI-2 caused a significant increase 
of the final setting time from approximately 18–20 min. When assessing the material compression 
strength, only the highest concentration of MRI-2 caused a significant decrease (Table 2).
Figure 2. Characterization of CPC/TA composite. a. SEM micrograph of TA particles (indicated by red arrows) 
mixed within the CPC matrix at 1000× magnification. Note that the TA is uniformly distributed within the cement 
matrix. b. Ex vivo MR imaging performance of smaller diameter/higher concentration MRI-1 vs. larger diameter/
lower concentration MRI-2 agents, at two different concentrations. Note that 0.1% w/w MRI-2 was the optimal 
combination providing MR-contrast enhancement.
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3.3. ex vivo Mri
Obvious CPC-to-bone contrast enhancement was seen in all samples. For the MRI-1 formulation 
with a lower core diameter, yet higher iron concentration, contrast was mostly characterized by the 
presence of a so-called blooming artifact. Further, at the settings used both applied concentrations 
led to a considerable visual overestimation of the size, with regards to the original defect perimeter. 
In contrast, the higher core diameter, lower iron concentration MRI-2 formulation proved to be 
optimal, as by visual inspection the contrast enhancement was corroborating closely with the 
original defect morphology (Fig. 2b). Based on this evidence, MRI-2 at a concentration of 0.1% wt/wt 
was selected only for the following tests and the final in vivo evaluation.
3.4. BMP-2 immobilization and release
The amount of BMP-2 immobilized on the surface of the beads was measured by ELISA. The assay 
showed that it was possible to immobilize relatively high amounts of BMP-2 on the substrates 
using an aminosilane linker. The measured amount was about 4.97 ± 0.86 µg of BMP-2 per 12.5 µL 
bead suspension, i.e. approximately 50% of the originally added 10 µg.
The remaining 1.98 ± 0.72 µg were measured in the supernatant and 2.54 ± 1.81 in the washing 
medium.
To quantify the released BMP-2 and its biological activity, the complementary ELISA and 
BRE-Luc tests were carried out. Both detection methods showed a progressive release during 
the observational period of 7 days. The presence of the hydroxyapatite coating induced a 
double amount of growth factor to be released after both 3 and 7 days, compared to the non-
coated beads (Fig. 3a). BRE-Luc data (Fig. 3b) showed that at least half of the released protein 
measured by ELISA remained biologically active.
3.5. In vivo Mri
The surgical procedure did not lead to any adverse and unexpected reactions. All animals recovered 
within a few hours post-surgery and none were restricted in their movements. Rats were monitored 
during the whole experimental period and no evident signs of discomfort nor weight loss were 
observed. Eight weeks post-implantation, all femoral condyles were retrieved. At a macroscopical 
Table 2. Comparison of size of the TA beads and effect on setting time. Two sets of beads incorporating different 
contrast agents formulations, namely MRI-1 and MRI-2, at both 0.1 and 0.5% w/w concentrations, were tested 
(* = P < 0.05).
Sample
Core size  
(μm)
Total size  
(μm)
Initial setting time 
(min)
setting time 
(min)
Mechanical loading  
(N)
CPC - - 3.91 ± 0.22 17.94 ± 0.44 75.99 ± 20.51
MRI-1 0.1% w/w 0.2–0.3 1.68 ± 0.86 3.94 ± 0.36 18.64 ± 0.43 68.06 ± 9.16
MRI-1 0.5% w/w 0.2–0.3 1.68 ± 0.86 4.98 ± 0.44 19.52 ± 0.43 66.80 ± 9.87
MRI-2 0.1% w/w 0.5–1.2 1.65 ± 0.78 4.58 ± 0.36 19.38 ± 0.41* 67.97 ± 13.02
MRI-2 0.5% w/w 0.5–1.2 1.65 ± 0.78 5.58 ± 0.37 20.24 ± 0.39* 65.44 ± 7.02*
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visual inspection, no clear differences were observed between the Empty, CPC and MRI groups, 
whereas obvious areas of new bone formation were detected in the group containing BMP-2.
MR images obtained 4 weeks post-implantation showed a partial healing of the untreated 
bone defects, which appeared to be progressed at week 8. No reliable observations could 
be made within the CPC group without additives, as the implanted material could not be 
reliably localized among the surrounding natural bone at either time point. In contrast, the 
incorporation of the MRI-2 contrast agent provided information about the correct localization 
of the injected material. Interestingly, also one undesired event could immediately be found, i.e. 
the formation of an evident crack in the center of one of the implanted cements. In this group, 
the MRI-2 contrast enhancement could still be detected 8 weeks following the implantation. 
Finally, similar contrast was observed at 4 weeks in the presence of the MRI-2/BMP-2 sample. 
This contrast had disappeared at week 8. Moreover, in this group an obvious region of newly 
formed bone could be localized inside, as well as outside the site of CPC injection (Fig. 4).
3.6. histology and micro ct for bone volume quantification
In none of the histological sections an adverse tissue reaction or signs of severe inflammation 
were found. Micro CT observation as well as HE and EVG staining showed a uniform bone 
reaction in all groups, and combined information from histological slides and micro CT (Fig. 5a) 
allowed the location of the original defect site within the condyle. Upon light microscopical 
Figure 3. In vitro BMP-2 release measured by a. ELISA and b. BRE-Luc assay. Both graphs compare the release from 
HA-coated beads against not coated beads. Results from both assays showed enhanced BMP-2 release in the 
presence of the coating. The BRE-Luc assay showed that, in the presence of the coating, the amount of bioactive 
released BMP-2 was relatively higher compared to the release in absence of coating.
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inspection, all defect areas appeared to be filled by newly formed trabecular bone. Bone 
marrow-like tissue was observed in between the bone voids and fibrotic tissue was absent. 
Despite the decalcification procedure, still traces of the implanted CPC were present in both 
CPC and MRI groups, whereas they could not be found in samples from the MRI/BMP2 group.
The original 3 × 3 mm defect area was selected to quantify the bone volume percentage. Eight 
weeks after implantation, the results showed significantly enhanced bone formation only in the 
presence of BMP-2, whereas no differences were detected between the other three groups (Fig. 5b).
4. discussion
The present study aimed to test the feasibility of a theranostic agent, i.e. an agent that 
simultaneously is capable to enhance the MR bone contrast, as well as enhance the osteogenic 
properties of CaP bone cement. Both in vitro and in vivo assays were performed. The TA as used, 
was a nanocomposite of silica beads, in which an iron oxide core and a silane linker-modified 
and calcium phosphate coated surface for BMP-2 immobilization were structurally integrated. 
The main in vivo implantation results showed a long-term MR contrast enhancement, as well as 
improved osteogenic capacity, by means of new bone formation.
Figure 4. In  vivo  MRI. Representative 2D slides selected from 3D-acquired datasets of rat femoral condyle 
defects from the four experimental groups, acquired by Zero Echo Time MRI sequence at 4 and 8 weeks post-
implantation. Red arrows indicate the location of the defect. 
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Theranostic agents are a class of imaging probes explored for the simultaneous visualization 
of drug delivery and therapeutic outcomes  [8]. Conveniently, many imaging agents can be 
easily upgraded to theranostic agents. For example, iron particles, currently the most popular 
MR contrast agents [9], have been often selected for theranostic applications, as their surface 
coating allows straightforward chemical linkage and bioactive molecules loading  [10]. In an 
initial study from our group, USPIOs were directly incorporated into CaP-based scaffolds, as 
enhancers of the implant-to-bone contrast. Despite providing sufficient imaging contrast, this 
approach had many practical drawbacks. Mainly, the ultra small iron oxide particles (USPIOs) 
negatively affected the setting and mechanical properties of the injectable material[11]. 
Therefore, in a follow-up study, USPIOs were encapsulated into inert silica, with the purpose 
to reduce aspecific reactivity in the cement setting reaction  [12]. In the present study, the 
same approach was used to synthesize two sets of silica particles, both encapsulating iron 
oxide, but differing by core size and iron particles-to-silica ratio. Besides the advantage of 
reducing unspecific reactivity, mesoporous silica has been extensively studied with regard to 
its applications for drug delivery and loading of bioactive molecules [13], [14] and [15].
As first principal results of this study, the characterization of the particles and ex vivo MRI 
data were used for the selection of one TA composition for the final animal work. Although 
the MRI-2 showed a significant increase in final cement setting time, we regarded this effect of 
lesser importance, as the increase from 18 to 20 min would be irrelevant for clinical handling. 
Figure 5. Micro CT and histology for bone volume quantification. a. Qualitative µCT and histological evaluation. 
Representative 2D-µCT and corresponding H&E stained sections from the CPC group 8 weeks post-implantation. The 
dashed circle indicated the original defect area. b. Quantitative evaluation of bone formation. Bone formation was 
measured within the original defect area, in the four experimental groups, 8 weeks after implantation. Bone percentage 
in all groups was around 60–70%, while the MRI/BMP2 group showed a significantly enhanced bone formation (P < 0.05).
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In stead, the MRI-2 by visual inspection exhibited a region of hypointensity, which at the MRI 
settings used more closely resembled the original area of the CPC-filled defect. It is important 
though to realize that shape measurements with any iron-containing MRI contrast agent will 
always be irreliable, as such agents are always be susceptible to so-called blooming effects. 
This type of artifact indeed was seen at both MRI-1 and MRI-2. It would ideally be possible to 
perform quantitative assessments on this effect with phantom studies, combined with proper 
calibration of the image thresholding. Such quantification however was not the aim for the 
current work, where image settings were always kept constant.
After proper imaging contrast was achieved, we focused on the osteogenic protein. 
A recent study from Elhert et  al.  [16]  sought to investigate the immobilization methods of 
BMP-2 on ceramic bone replacement materials. Only in the presence of the aminosilane linker 
notable amounts of BMP-2 could be immobilized. Considering these results, in the present 
study, the same approach was used to immobilize BMP-2 on the surface of the MRI-2 silica 
particles. Of course, also the amount of BMP-2 provided at the implant site is determining for 
its function [17], [18] and [19], and furthermore appropriate amounts can vary among different 
scaffold materials. For CPCs ranges from 2 to 30 µg have been investigated[20] and [21], while 
several studies report enhanced bone formation already at the lowest doses [22],[23] and [24]. 
In the present study therefore a final concentration of ~5 µg per defect was adsorbed onto the 
beads and incorporated into each CPC scaffold.
The possibilities to further modulate BMP-2 release in terms of kinetics and concentration 
ranges, have been extensively explored. One option  to modulate release is to provide the 
carrier with a coating. In the present study, the silica particles were coated by precipitated 
hydroxyapatite, following BMP-2 adsorption. The study of Boix et  al. showed that BMP-2 has 
high affinity for hydroxyapatite, mainly influenced by the abundance of calcium or phosphate 
ions, especially at low pHs [25]. These results support the hypothesis that in our study, BMP-2 
might have higher affinity for the coating rather than the functionalized silica support. It is 
therefore realistic to expect a fast release of the coating from the silica surface, together 
with the attached BMP-2. Based on the BRE-Luc assays results, upon release, the coating also 
contributed to preserve higher concentrations of bioactive BMP-2.
Finally, we tested  in  vitro  the setting time and compressive strength of the CPC. Such 
handling properties are often overlooked but of critical interest to surgeons. It was shown that 
handling was not significantly affected by the incorporation of the TA, corroborating the data 
of our previous study [12]. The material handling remained acceptable within a range, which still 
meets the clinical demands when repairing non-loading sites [24].
The TA-CPC was thereafter also tested  in vivo, upon injection in a femoral condyle defect 
model in rats. The animal model is a well-established defect model for testing injectable as 
well as pre-set bone substitute materials [26] and [27]. The relatively easy surgical procedure, 
together with the easily accessible location for imaging procedures, makes this model optimal 
for the purposes of our study. Again corroborating our previous data  [12], standard non-
modified CPC was not distinguishable from the surrounding bone tissue. In contrast, the TA-CPC 
remained detectable by MRI up to eight weeks post-implantation. However, in most samples 
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from the MRI/BMP2 group, contrast was seen at 4 weeks, but no longer observable after 8 
weeks. Such observation is not due to a decay of the generated signal, but rather indicative 
that CPC remodeling and degradation was accelerated by the activity of BMP-2. Moreover, the 
results of this group evidenced that the TA was released from the CPC upon its degradation, 
but not incorporated into the newly formed bone, as the contrast enhancement would still be 
detectable otherwise. This property makes the TA particularly attractive for longitudinal and 
material degradation studies. Furthermore, for these type of beads is has been described that 
upon release from the scaffold, they can be cleared through intestinal macrophages and, due 
to their size, renal filtration[28] and [29], overcoming toxic accumulation issues. Finally, also the 
histological evaluations proved that no traces of the implanted CPC could be retrieved in the 
MRI-BMP/2 group, supporting the notion that indeed the MR contrast disappearance 8 weeks 
post-implantation was solely due to the CPC scaffold degradation.
5. conclusions
Multimodal and multifunctional theranostic probes are forming a cutting-edge technology, in 
which the advantages of both advanced imaging and therapeutic strategies can be combined. 
In the present study, we have described a bead-based formulation composed of an iron oxide 
core for MR contrast enhancement, embedded in a mesoporous silica matrix on which BMP-2 was 
immobilized. Our strategy allowed to overcome negative interference of the addition of a contrast 
agent to the biomaterial properties. Furthermore, bioactive BMP-2 could be efficiently released 
from the carrier-beads, leading to localized and effective bone regeneration. The described TA 
was shown to be suitable for longitudinal material degradation and bone healing studies.
6. references
1 F.C.J. Van de Watering, J.D.M. Molkenboer-
Kuenen, O.C. Boerman, J.J.J.P. van den Beucken, 
J.A. Jansen. Differential loading methods for 
BMP-2 within injectable calcium phosphate 
cement. J Control Release, 164 (2012), pp. 283–290
2 V. Mouriño, A.R. Boccaccini. Bone tissue 
engineering therapeutics: controlled drug 
delivery in three-dimensional scaffolds J R Soc 
Interface, 7 (2010), pp. 209–227.
3 M. Weiger, M. Stampanoni, K.P. Pruessmann. Direct 
depiction of bone microstructure using MRI with 
zero echo time Bone, 54 (2013), pp. 44–47
4 P. Prabhu, V. Patravale. The upcoming field of 
theranostic nanomedicine: an overview. J Biomed 
Nanotechnol, 6 (2012), pp. 859–882.
5 R.P. Félix Lanao, J.W. Hoekstra, J.G. Wolke, S.C. 
Leeuwenburgh, A.S. Plachokova, O.C. Boerman et 
al. Porous calcium phosphate cement for alveolar 
bone regeneration. J Tissue Eng Regen Med (2012)
6 M.A. Lopez-Heredia, K. Sariibrahimoglu, W. 
Yang, M. Bohner, D. Yamashita, A. Kunstar et al. 
Influence of the pore generator on the evolution 
of the mechanical properties and the porosity and 
interconnectivity of a calcium phosphate cement. 
Acta Biomater, 8 (2012), pp. 404–414.
7 N. Ehlert, A. Hoffmann, T. Luessenhop, G. Gross, 
P.P. Mueller, M. Stieve et al. Amino-modified 
silica surfaces efficiently immobilize bone 
morphogenetic protein 2 (BMP2) for medical 
purposes. Acta Biomater, 4 (2011), pp. 1772–1779
8 E. Terreno, F. Uggeri, S. Aime. Image guided 
therapy: the advent of theranostic agents. J 
Control Release, 161 (2012), pp. 328–337
9 J.W. Bulte, D.L. Kraitchman. Iron oxide MR contrast 
agents for molecular and cellular imaging. NMR 
Biomed, 17 (2004), pp. 484–499
10 J. Xie, S. Lee, X. Chen. Nanoparticle-based theranostic 
agents. Adv Drug Deliv Rev, 62 (2010), pp. 1064–1079
97
A
 TH
ER
A
N
O
STIC
 A
G
EN
T FO
R C
O
M
BIN
ED
 BO
N
E IM
A
G
IN
G
 A
N
D
 REG
EN
ER
A
TIO
N
5
11 Y. Sun, M. Ventura, E. Oosterwijk, J.A. Jansen, 
X.F. Walboomers, A. Heerschap. Zero echo time 
magnetic resonance imaging of contrast-agent-
enhanced calcium phosphate bone defect fillers. 
Tissue Eng Part C Methods, 19 (2013), pp. 281–287
12 M. Ventura, Y. Sun, V. Rusu, P. Laverman, P. 
Borm, A. Heerschap et al.Dual contrast agent for 
computed tomography and magnetic resonance 
hard tissue imaging. Tissue Eng Part C Methods, 19 
(2013), pp. 405–416
13 X. Shi, Y. Wang, L. Ren, N. Zhao, Y. Gong, D.A. 
Wang. Novel mesoporous silica-based antibiotic 
releasing scaffold for bone repair. Acta Biomater, 5 
(2009), pp. 1697–1707
14 X. Shi, Y. Wang, R.R. Varshney, L. Ren, F. Zhang, 
D.A. Wang. In-vitro osteogenesis of synovium stem 
cells induced by controlled release of bisphosphate 
additives from microspherical mesoporous silica 
composite. Biomaterials, 30 (2009), pp. 3996–4005
15 N. Ehlert, P.P. Mueller, M. Stieve, P. Behrens. 
Immobilization of alkaline phosphatase on 
mesoporous silica. Microporous Mesoporous 
Mater, 131 (2010), pp. 51–57
16 N. Ehlert, P.P. Mueller, M. Stieve, T. Lenarz, P. 
Behrens. Mesoporous silica films as a novel 
biomaterial: applications in the middle ear. Chem 
Soc Rev, 42 (2013), pp. 3847–3861
17 K.E. Chenard, C.M. Teven, T.C. He, R.R. Reid. Bone 
morphogenetic proteins in craniofacial surgery: 
current techniques, clinical experiences, and the 
future of personalized stem cell therapy. J Biomed 
Biotechnol, 2012 (2012), p. 601549
18 Jiansheng Su, Hongzhen Xu, Jun Sun, Xue Gong, 
Hang Zhao. Dual delivery of BMP-2 and bFGF from a 
new nano-composite scaffold, loaded with vascular 
stents for large-size mandibular defect regeneration. 
Int J Mol Sci, 14 (2013), pp. 12714–12728
19 Nancy E. Epstein. Complications due to the use 
of BMP/INFUSE in spine surgery: the evidence 
continues to mount. Surg Neurol Int, 4 (2013), pp. 
S343–S352
20 F.C. van de Watering, J.J. van den Beucken, S.P. 
van der Woning, A. Briest, A. Eek, H. Qureshi et al. 
Non-glycosylated BMP-2 can induce ectopic bone 
formation at lower concentrations compared to 
glycosylated BMP-2. J Control Release, 159 (2012), 
pp. 69–77
21 K. Lee, E.A. Silva, D.J. Mooney. Growth factor 
delivery-based tissue engineering: general 
approaches and a review of recent developments. 
J R Soc Interface, 8 (2011), pp. 153–170
22 M. Kisiel, A.S. Klar, M.M. Martino, M. Ventura, J. 
Hilborn. Evaluation of injectable constructs for 
bone repair with a subperiosteal cranial model in 
the rat. PLoS One, 8 (2013), p. e71683
23 M. Kisiel, M. Ventura, O.P. Oommen, A. George, 
X.F. Walboomers, J. Hilborn et al. Critical 
assessment of rhBMP-2 mediated bone induction: 
an in vitro and in vivo evaluation. J Control Release, 
162 (2012), pp. 646–653
24 D. Guo, K. Xu, X. Zhao, Y. Han. Development of 
a strontium-containing hydroxyapatite bone 
cement. Biomaterials, 26 (2005), pp. 4073–4083
25 T. Boix, J. Gómez-Morales, J. Torrent-Burgués, 
A. Monfort, P. Puigdomènech, R. Rodríguez-
Clemente. Adsorption of recombinant human 
bone morphogenetic protein rhBMP-2 onto 
hydroxyapatite. J Inorg Biochem, 99 (2005), pp. 
1043–1050
26 C. Schouten, J.J. van den Beucken, L.T. de Jonge, 
E.M. Bronkhorst, G.J. Meijer, P.H. Spauwen et 
al. The effect of alkaline phosphatase coated 
onto titanium alloys on bone responses in rats. 
Biomaterials, 30 (2009), pp. 6407–6417
27 C. Castellani, G. Zanoni, S. Tangl, M. van Griensven, 
H. Redl. Biphasic calcium phosphate ceramics 
in small bone defects: potential influence of 
carrier substances and bone marrow on bone 
regeneration. Clin Oral Implants Res, 20 (2009), 
pp. 1367–1374
28 K. Sato, S. Yokosuka, Y. Takigami, K. Hirakuri, K. 
Fujioka, Y. Manome et al. Size-tunable silicon/iron 
oxide hybrid nanoparticles with fluorescence, 
superparamagnetism, and biocompatibility. J Am 
Chem Soc, 133 (2011), pp. 18626–18633
29 H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, 
B. Itty Ipe et al. Renal clearance of quantum dots. 
Nat Biotechnol, 25 (2007), pp. 1165–1170
98

Yi Sun1
Ole Brauckmann2
Donald R. Nixdorf3
Arno Kentgens2
Michael Garwood4
Djaudat Idiyatullin4
Arend Heerschap1
1Radiology, Radboud University Nijmegen Medical Centre, 
Nijmegen, Gelderland, Netherlands,  
2Solid State NMR, Institute of Molecules and Materials, Radboud University Nijmegen 
3Division of TMD and Orofacial Pain Department of Diagnostic 
and Biological Sciences, University of Minnesota, MN, United States 
4Center for Magnetic Resonance Research, 
University of Minnesota, MN, United States, Netherlands. 
6C H A P T E R31P Mri of huMan tooth with structural contrast uncovered 
By nuclear overhauser effect 
enhanceMent
31P M
RI O
F TEETH
 EN
H
A
N
C
ED
 W
ITH
 N
U
C
LEA
R O
V
ERH
A
U
SER EFFEC
T
6
aBstract
Phosphorous Magnetic Resonance imaging (31P MRI) of human mineralized tissue is challenging, 
owing to its low MR sensitivity and extremely short T
2
* value. By using zero echo time (ZTE) and 
sweep imaging with Fourier transformation (SWIFT) acquisition sequences, 3D 31P MR images 
were obtained of human tooth. These images provide direct information on the mineral structure 
and density of tooth. Quantitative density estimation agreed with the known mineral density 
difference between dentin and enamel. Furthermore, upon proton spin saturation a Nuclear 
Overhauser Effect (NOE) is observed on the 31P signal of tooth. In NOE-SWIFT/ZTE images, the 
signal to noise ratio (SNR) of the whole tooth is enhanced up to 20%. Most importantly, there 
is a difference in NOE enhancement between dentin and enamel, providing a structural filter 
in the imaging of these components. The nature of this difference was further investigated in 
solid-state NMR experiments, showing the existence of distinct NOE dynamics for dentin and 
enamel. The faster and more pronounced NOE build-up in dentin most probably arose from its 
amorphous phase and is then transferred to the crystalline phase by spin diffusion. In this study, 
a novel method for imaging human teeth with additional structural contrast is demonstrated.
significance 
Here we demonstrate successful 3D 31P MR imaging of human teeth, which is a true volumetric 
and quantitative measurement of 31P content. We also show that a signal enhancement can be 
obtained. Moreover, we obtain signal enhancement which show a regional difference between 
dentin and enamel, is later confirmed in an in-depth NMR validation study of the Nuclear 
Overhauser Enhancement. This difference is interpreted based on the known differences in their 
microstructure. The process of identifying the sources of NOE contributes to the knowledge 
on the nanostructures of human mineralized tissues. The 31P MR imaging approaches presented 
here also have great potential for diagnosis of bone related disease such as osteoporosis.
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1. introduction
The early diagnosis of bone related disease, the development of bone tissue engineering and 
regenerative dentistry requires more informative imaging1,2. Since densely mineralized tissues 
such as bone and tooth largely consists of hydroxylapatite, a crystalline calcium phosphate, 
the imaging of phosphate is expected to reveal a direct picture of their mineral structures and 
content. Such measurements may be realized by 31P MRI, but it is challenging to obtain a useful 
MR signal from 31P nuclei in bone and tooth3, in particular because of the short persistence 
of its detectable signal (ultra short T
2
* relaxation time). Because of this limitation, acquisition 
sequences which have negligible echo time, such as ZTE (Zero Echo Time) or SWIFT (Sweep 
imaging with Fourier Transformation), used for 1H MRI of mineralized tissue4,5,6,7,8, seem most 
suitable. An additional challenge is the much lower SNR of the 31P signal from human mineralized 
tissue compared to 1H signal from its water content. Therefore, an enhancement of the 31P signal 
in MR imaging will be helpful.
The aim of this study is first to investigate if informative 31P MR images of human teeth 
can be obtained by SWIFT and ZTE pulse sequences. Secondly, we explore the 1H-31P nuclear 
Overhauser effect (NOE) of the 31P signal as a potential tool for signal enhancement and for the 
investigation of the mineral structure of teeth.
2. Matherials and Methods
2.1. extracted human teeth samples
Four extracted teeth were harvested as waste tissue and selected for ex vivo imaging. No 
data that identified patients were recorded. Teeth were stored in an isotonic saline solution, 
containing 0.1% of sodium azide as an antimicrobial agent. Before the MRI experiments, water 
on the surface of teeth was removed using a paper towel, and they were then wrapped with 
Teflon. A maxillary left second molar and a mandibular right second molar were chosen to 
test the feasibility of 31P MRI to access their overall anatomy and mineral content. In order to 
further test if 31P MRI can detect mineral breakdown, two teeth with defects were selected: a 
mandibular right first premolar, with buccal pit lesions and distal lingual lesion in the crown; a 
maxillary left canine, with restoration at the mesial/lingual surface.
2.2. Mr hardware and pulse sequences
MRI was performed on a 9.4T MR system (Agilent-Varian) with a home-built double channel coil. The 
phosphorus RF probe consists of two parallel copper loops of 1.5 cm in diameter, at 1 cm distance. 
The proton RF-coil is a copper single loop surface coil with 1.5 cm in diameter, positioned centrally 
in between both phosphate coil loops but oriented perpendicular to them. The minimum dead time 
between excitation and acquisition is 2 µs for 1H nuclei and 2.5 µs for 31P nuclei.
The first pulse sequence applied in this study is the SWIFT pulse sequence9. It consists of a 
simple series of RF pulses, incremented gradients, and simultaneous data acquisition (Fig.1). The 
excitation pulse is an amplitude and frequency modulated hyperbolic secant (HS1) pulse at low 
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peak power, which excites a large bandwidth, with a flat excitation profile10. The scheme employs 
a sequence of excitation pulses with short repetition time TR that exceeds the pulse length. The 
images are reconstructed from the raw data using 3D back-projection reconstruction. 
The second pulse sequence employed in this study is the zero echo time (ZTE) sequence11,12. 
It comprises of a hard small flip angle pulse for excitation that covers a broad bandwidth. The 
read-out gradient is already on, and a given direction is ramped up followed by RF excitation 
(Fig. 1), this minimal gradient changes reduce eddy current effects and so make ZTE imaging 
highly robust. After the necessary dead time delay, the frequency encoded free induction 
decay is sampled. The sequence is then repeated for the acquisition of the next projections. A 
three-dimensional back-projection algorithm is used for image reconstruction.
2.3. Mri experiments
Proton SWIFT images were acquired with an excitation bandwidth of 125 kHz, a flip angle (FA) 
15°, a field of view (FOV) of 3*3*3 cm, and 32000 spokes; the repetition time (TR) was 2.5 ms 
which included 2 ms total pulse length, the total acquisition (TA) time was 100 sec. The image 
was reconstructed to a matrix of 256*256*256 pixels. Phosphorus SWIFT and ZTE imaging were 
both acquired with an excitation bandwidth of 62.5 kHz, an FA of 7°, an oversampling factor of 
4, a TR of 200 ms, a FOV of 3*3*3 cm3, TA was 60 s for a moderate resolution (512 spokes) or 8 
mins for a high resolution image (4096 spokes), the receiver duty cycle (d
rec
) was 0.5 in all the 
experiments. Almost all other parameters are as similar as possible, except the short hard pulse 
excitation (5 µs length) applied in ZTE. The global T
1
 and T
2
* relaxation times of the 31P spins 
were also obtained (for the whole tooth), by inversion recovery and measuring line widths 
respectively. Two regions of interests (ROIs) that cover dentin and enamel were then manually 
drawn on the cross-sectional slices of 31P images, to compare their difference in SNR. The SNR is 
evaluated by calculating average signal divided by standard deviation.
2.4. nuclear overhauser effect enhanced 31P Mr imaging
For the 1H-31P NOE enhanced experiments, the proton spins were saturated for 1.282 s during 
TR (1.482 s) by a hard pulse train (Figure 1). It comprised 129 hard pulses, of 400µs width with a 
pulse delay of 9.6 ms, by which full saturation of the proton magnetization was achieved. This 
preparation pulse train for the NOE is the same for both ZTE- and SWIFT-images. The delay 
between the last 1H saturation pulse and the 31P excitation pulses is also the same (3.004 ms). 
To compare with the non-NOE enhanced experiment, the saturation pulses were turned off, 
but TR remained unchanged. The TA for 31P MRI with or without NOE were both about 48 mins.
2.5. noe validation study
To quantify the NOE build-up and to identify the source of the enhancement, we performed 
a series of solid-state NMR spectroscopy experiments. Dentin and enamel were separated and 
crushed into powder, then measured on a 9.4 T solid-state NMR system (Agilent-Varian), with a 
3.2 mm rotor and a H-X-Y triple resonance probe head. 
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The 1H nuclei were saturated by a train of long (1 ms) soft pulses (ν
1
 = 450 Hz) separated by 
a delay of 1 ms, with a total saturation time ranging from 50 to 500 seconds. The NOE build-up 
of the 31P signal was measured by recording the FID, after the excitation with a 5.5µs hard pulse. 
The increase in signal intensity as a function of saturation time can be modeled by a mono-
exponential function. 31P NMR spectra were recorded using the same hard pulse. 1H NMR 
spectra were recorded on a 20 T MR spectrometer using a 1.6 mm probe head and a hard pulse 
of 2.9 µs for excitation. 1H and 31P NMR spectra were recorded using magic angle spinning (MAS) 
at 10 kHz and 35 kHz to identify the source of the NOE enhancement in dentin and enamel. 
1H-31P cross-polarization (CP) is a coherent transfer based on the static dipolar interaction 
of coupled spins and therefore sensitive to distances and mobility in the kHz regime. To further 
analyze the spectral components involved in this process, 1H-31P CP spectra at different contact 
times (100 µs - 15 ms) were recorded for dentin and enamel. 
Figure 1. Schematic representation of SWIFT and ZTE pulse sequences with saturation pulses on the proton channel. 
For SWIFT, the excitation pulse is divided into many segments, each having RF power on for a certain duration, 
followed by a delay with RF power off. Data acquisition in SWIFT is performed at the delay after each segment 
and after the excitation pulse (yellow colored). For both pulse sequences, the gradients were set to the required 
direction and amplitude. They remained constant until adjusted for the next repetition. The saturation pulse train 
comprises 129 hard pulses of 400 µs width with a delay of 9.6 ms in between, is the same for SWIFT and ZTE.
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3. results
3.1. zte and swift 31P Mr images
The proton MR image of a human maxillary left second molar tooth shows several anatomical 
details such as high signal intensity for pulp (Fig. 2 B). The hyperintense regions close to the 
coronal and buccal surface are water and soft tissue residuals. From the 1H MR image in the 
apical-coronal direction, it is clear that enamel exhibits less intense signal than dentin (Fig. 2 d). 
In order to optimize the pulse sequences for 31P MRI of teeth, we measured the relaxation 
times of 31P nuclei: the global (whole tooth) T
2
* of 31P was around 100 µs and global T
1 
was around 
130 s for this human maxillary left second molar tooth. For other teeth samples, similar T
2
* were 
obtained, and T
1
 values were all within the range of 100~200 s with some variation between healthy 
teeth and diseased teeth. In 31P MR images obtained in 60 s (512 spokes), the rough contour of the 
molar tooth is already visible (Fig. 2 C). In the higher resolution 31P MR image acquired in about 8 
mins (4096 spokes), better delineation between structures and more detailed information can 
be seen: i.e. in cross-sectional slices, enamel with higher phosphate content had a higher signal 
intensity compared to dentin which contains less phosphate (Fig. 2 E&F). The global SNR of the 31P 
signal of enamel was measured to be 50% higher than that of dentin. 
In general, the 31P MR images obtained with ZTE offered better SNR than those obtained 
with the gapped SWIFT (compare Fig. 2 E with 2 F). The global SNR of the ZTE images is 39% 
higher than the global SNR of the SWIFT images (25.3 versus 18.2). The 1H and 31P images of 
other teeth samples are also shown: for the diseased teeth, 31P MR images clearly identifier the 
mineral breakdowns (support information).
3.2. Mri and spectroscopic validation of noe enhancement
3.2.1. NOE enhancement in 31P MR imaging
Irradiation at the 1H frequency generates a positive NOE for the 31P MR signal of teeth (Fig.3). The 
global NOE enhancement in the 31P MR images is around 20% (an SNR of 21.8 in SWIFT MR images 
with NOE versus SNR of 18.2 in SWIFT MR images without NOE, measured over the whole object). 
The enhancement is not the same for all regions: subtraction of the SWIFT MR images with NOE from 
that without NOE clearly reflect that shape of dentin, while enamel is not visible in this subtraction 
image (Fig. 3). Thus the difference in NOE enhancement provides a structural contrast.
3.2.2. NOE validation study
To investigate the origin of the 1H-31P NOE enhancements in teeth, we performed solid-
state NMR on separated dentin and enamel materials. In 1H MAS spectra of both enamel and 
dentin, the water resonance at around 5 ppm is the most pronounced signal (Fig. 4 left). In 
enamel, a characteristic resonance for the hydroxyl group in hydroxyapatite arises at around 
-0.1 ppm, while no peak could be seen at this chemical shift for dentin. The other resonances 
in the spectrum of dentin arise from the organic matrix (Fig. 4 left). The 31P MAS spectrum 
shows a lower signal intensity for dentin compared to enamel (Fig. 4 right). To investigate the 
composition of the minerals and the distances between 1H and 31P nuclei, cross-polarization 
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Figure 2. MRI of human maxillary left second molar tooth. A. Picture of the molar tooth. B. 1H MR image of molar 
tooth. C. 31P MR image (medium resolution acquired in 60 s). D. 1H MR image of this molar tooth at apical-coronal 
direction. E. 31P high-resolution MR image obtained using the SWIFT experiment (8 mins). F. 31P high-resolution 
MR image obtained employing ZTE (8 mins). Images D, E, F are all cross-sectional slices in the apical-coronal 
direction, represented by the yellow line in image B, in which dentin and enamel could be clearly separated. 
Figure 3. 31P MR images of maxillary left second molar tooth obtained with SWIFT. A. SWIFT image with 1H 
irradiation at the 1H frequency for 1.282 s B. SWIFT image without 1H irradiation. C. The subtraction of A and B 
showed a positive NOE for the 31P MR signal, mainly from the dentin. The yellow dash-dot line represents the 
contour of the enamel. 
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(CP) experiments were performed. In dentin, besides a crystalline phase, an amorphous phase 
is present which is visible as a broader linewidth at short contact times13,14. The 31P line shape 
of dentin observed at long CP contact times is narrower and very similar to the line shape 
observed in the 31P and NOE enhanced 31P spectra (support information).
The 1H-31P NOE build-up as a function of saturation time can be modeled with a mono-
exponential function. Clear differences between the NOE build-up in dentin and enamel can 
be seen. After 500 s 1H saturation, the NOE enhancement was 31% for dentin and 14% for 
enamel. The enhancements for dentin reaches a plateau at long saturation times, while for 
enamel the maximum is not yet reached. The measured maximum NOE enhancement in dentin 
is higher than in enamel, additionally the NOE build-up in dentin is much faster (Figure 5 & 6). 
The mono-exponential models for NOE build-up indicate a maximum enhancement of 31% for 
dentin compared to 19% for enamel, with build-up rate of 
~
116 s for dentin and 
~
310 s for enamel 
respectively. To assess the source of the enhancement, the 31P spectrum of dentin and enamel 
were deconvoluted using the least number of components needed to fit the observed line 
shape. The two 31P components of dentin equally contribute to the NOE build-up (Fig. 5). Also 
the three components of enamel behave similar in the slower NOE build-up (Fig. 6). Previously 
the components of dentin have been assigned to a crystalline and an amorphous part13. For 
enamel a three-component model, in agreement with earlier reports in literature, was used14. 
The assignment of the different components in enamel is still under debate. The central line 
is assigned to interior phosphate groups. The shoulders are assigned to unprotonated and 
protonated phosphate surface groups14.
Figure 4. 1H MAS spectra (ν
r
=35kHz, left) and 31P MAS spectra at (ν
r
=10kHz, right) of dentin and enamel, the spectra 
are recorded with the same parameters and processed in the same way. The signal intensity of the spectra is scaled 
by the weight. Dentin: blue lines. Enamel: green lines. In the 1H NMR spectra (left), the peak at around 5 ppm is water; 
the peak at around -0.1 ppm is from hydroxyl groups. Other peaks in the 1H NMR spectra of both dentin are from 
the organic matrix. In the 31P spectra (right), enamel has higher intensity due to higher degree of mineralization.
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4. discussion
As the major component of human mineralized tissue like tooth and bone, is hydroxylapatite 
(HA, Ca
10
(PO
4
)
6
(OH)
2
)15, the application of 31P MR imaging gives direct information on its mineral 
content. Solid-state 31P NMR of hydroxylapatite has been applied to identify mineralization in 
bone16,17,18. Solid-state 31P MRI has been employed to image human teeth19, but its low resolution and 
long scanning time limits its application. Furthermore, it was not possible to resolve the difference 
in phosphate content between dentin and enamel. In this study, by using the SWIFT and ZTE 
sequences for 31P MR imaging, these structures can be delineated. Subsequently, 31P MRI of bone has 
Figure 5.The deconvolution of the dentin 31P signal in 2 components and the NOE build-up of these components 
together with their mono-exponential models, indicates a build-up rate of 
~
116 s.
Figure 6.The deconvolution of the enamel 31P signal in three components and NOE build-up of these components 
together with their mono-exponential models, indicates a build-up rate of 
~
130 s.
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been performed20, also in an in vivo human study, but this required the extensive use of home-built 
MR hardware such as a frequency converter to enable detection of the 31P signal by means of the 
1H channel21, which is not desirable. Overall, MRI of 31P in human mineralized tissue is challenging, 
owing to its low MR sensitivity, very long T
1
, lower 31P content relative to 1H in water3 and short 
T
2
*19 (low spatial resolution). This low resolution could be improved by quadratic line narrowing22. 
In our study, ZTE showed higher efficiency due to the more effective hard pulse excitation over 
the gapped sweep pulse in SWIFT (in support information). The SNR of SWIFT is therefore lower 
compared to ZTE, which is proportional to the square root of d
rec 
(receiver duty cycle): SWIFT
SNR
/
ZTE
SNR
 (d
rec
 is 0.5 in this study). This difference is in agreement with experimental findings (SNR in 
31P ZTE is around 39% higher compared to SWIFT). However, extending the acquisition of SWIFT 
avoiding gaps, improved its SNR substantially23. With further improvements, both ZTE and SWIFT 
have potential for future clinical application in human bone and tooth imaging.
The NOE is the fractional change in the integrated NMR absorption intensity of a nuclear 
spin system upon saturation of a second coupled spin system24. 31P NOE enhancement by 1H 
irradiation has been widely reported for phosphate compounds in solutions25,26, but never in 
human mineralized tissue. The observed positive heteronuclear NOE was applied to enhance 
the signal intensity of 31P MR images in this study. Steady state NOE experiments show that the 
enhancement reaches its maximum value around 5T
1 
of 31P
, 
in agreement with our knowledge on 
heteronuclear NOE in the solid state27. Furthermore, from the 31P MR images, it is noticed that a 
more prominent NOE enhancement was observed for dentin.
Even though the main content of both dentin and enamel is hydroxylapatite, their 
microstructure is different: enamel consists mainly of highly crystalline apatite mineral (98 
wt%)28; besides being partly amorphous29 dentin also contains an organic matrix and water 
(hydration/interstitial water and type I collagen fibrils 20-25 wt%)30. The difference in their 
microstructure most likely explains the more prominent NOE observed in dentin compared to 
enamel and their different build-up rates.
The main difference in the 1H spectra of enamel and dentin is the more prominent hydroxyl 
resonance in enamel. Since this resonance polarizes in inverse-CP (31P1H) experiments28 and 
dentin shows higher enhancement compared to enamel, the hydroxyl group is probably not the 
source causing the enhancement in enamel and dentin. The NOE is a cross-relaxation process 
relying on fast molecular motions in the ns regime, whereas CP is a coherent polarization process 
effectuated through the static dipole interaction between coupled spins. As water resonance 
around 5 ppm remains, even after extensive drying of these materials this indicates that water is a 
structured element of these bio-minerals. After drying, the NOE still exists. It is well possible that 
fast motions of this water modulate the 1H-31P dipolar interaction on the ns time scale. It is the most 
plausible source of the NOE in enamel and dentin. We tried to selectively saturate 1H resonances 
to identify the source of the NOE (support information). However, due to 1H spin-diffusion (the 
polarization exchange by close spins via dipolar couplings) it proved impossible to selectively 
saturate a single proton resonance during the long build-up period of the NOE (hundreds of 
seconds). This is in agreement with experiment of synthetic apatite, showing exchange within 
milliseconds between all proton resonances31. We tried to identify differences in NOE efficiency for 
110
31P M
RI O
F TEETH
 EN
H
A
N
C
ED
 W
ITH
 N
U
C
LEA
R O
V
ERH
A
U
SER EFFEC
T
6
the different components in the 31P spectrum by deconvoluting the 31P spectra at different saturation 
times (Fig 5 and 6). For dentin we used a two-component model (crystalline and amorphous 
phase) and for enamel a three component model representing different phosphate resonances 
as discussed earlier. However, within the error of the analysis, all individual components in enamel 
and also those in dentin show similar enhancement and build-up dynamics. We attribute this to 31P 
spin-diffusion taking place during the NOE build-up process over hundreds of seconds.
In earlier one- and two-dimensional 1H- 31P CP-studies31,32, broader line widths were found 
for the amorphous phase of apatite. The broadening is attributed to a more heterogeneous 
environment at the crystal surface and the amorphous phase31. The CP-dynamics for dentin are 
similar to the dynamics observed in synthetic apatite systems32: the amorphous phase polarizes 
readily and the polarization vanishes at longer contact times (10-15 ms) leading to a narrower 31P 
spectrum. The narrower crystalline phase polarizes more slowly and plateaus after about 10 ms. 
The CP-dynamics of the separated minerals from dentin and enamel showed the same dynamics 
as reported in literature (support information). The 31P and NOE enhanced 31P spectra of dentin 
resemble the CP spectra at long polarization times. Therefore it is most probable that the faster 
and more pronounced NOE build-up in dentin arises in the amorphous phase and is transferred by 
spin diffusion to the crystalline phase. However, the fast 1H and 31P spin diffusion in dental mineral 
structure hampers a more specific identification of the components involved in this process.
Dual-energy X-ray absorptiometry (DEXA) is the gold standard in evaluating bone mineral 
density. It is more sensitive to the calcium content then phosphate due to its higher atomic mass 
and greater concentration. Compared to DEXA, 31P MRI has the advantages of not only being a 
direct assessment of mineral content but also being a true volumetric measurement. However, 
ultra-short dead times are needed for 31P imaging, to date only accessible in dedicated research 
scanners or custom-made hardware21. 
In this study, we demonstrated that with SWIFT and ZTE pulse sequences, informative 
3D 31P MR images of teeth could be obtained in a reasonable time. These images spatially 
resolved areas with different phosphate content such as in dentin and enamel. Moreover 
we demonstrated that a spatially variable enhancement of the 31P MR signal is possible by 1H 
irradiation, thus providing an additional structural filter in the imaging of teeth.
The difference in NOE enhancements for enamel and dentin offers a window on their 
mineral structure. A change in the microstructure (degradation/bioactivity) might also 
influence the NOE enhancement. Therefore, NOE enhanced 31P MR imaging has the potential to 
provide more insight in the contribution of artificial bone substitutes, such as synthetic calcium 
phosphate cement (CPC), to the recovery of bone by following changes in NOE enhancement. 
Apart from dental imaging, 31P MRI with SWIFT and ZTE with NOE enhancement might also be 
a valuable tool in the diagnosis of and treatment evaluation of osteoporosis and other bone 
diseases associated with mineral breakdown. 
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6. suPPort inforMation
6.1. 31P imaging of human tooth
A 3d surface rendering on the 3d 31P imaging of human maxillary left second molar, made from 
MevisLab. The surface, its three roots and the pupal cavity could be clearly seen (Fig. 1).
6.2. human tooth: enamel and dentin
The mineral of human tooth enamel and dentin was identified as a calcium-phosphate with a 
hydroxylapatite structure (HA, Ca
10
(PO
4
)
6
(OH)
2
 ), it’s known that the its crystal (Fig. 2 C) and 
chemical properties are different from those of the well-defined synthetic HA. Dentin and 
enamel are the main mineral structure of human tooth, they have many differences in their 
composition and structure.
Mature enamel comprises 95 wt% carbonated apatite and <1% organic matrix. Enamel contains 
elongated mineral crystallites in the form of biological apatite (90% vol.) bonded by polymeric 
proteins and peptide chains (2% vol.) It has a hierarchical structure(Fig. 2 A) with crystals of 
tightly packed into rods (prisms) (width~5µm) (Reyes-Gasga  et al., 2012; Macho et al., 2003) and 
enclosed by polymeric sheaths (width 0.1 µm) (Fincham et al., 1999). The rods are highly aligned, 
approximately normal to the outer enamel surface (Lawn et al., 2009). On the other hand, dentin 
is a hydrated structure, composed of a mineral phase in the form of needle- and plate-shaped 
biological calcium-deficient, carbon-rich apatite crystallites (48% vol.) The main structural 
component of dentin is type I collagen fibrils impregnated, surrounded by mineral crystallites, 
which have c-axes aligned with the collagen fibril axis (Linde, 1989). Furthermore, dentin is 
hydrated with fluid (similar to plasma) to about 23% by volume (Nanci, 2008). Dentin contains 
multiple closely packed dentinal tubules of about 2µm diameter oriented between the pulp and 
dentin–enamel junction (Fig. 2 B). Each tubule is surrounded by a cuff of highly mineralized 
peritubular dentin and intertubular dentin between them (Gotliv & Veis, 2007). 
Figure1. 3D rendering of the 31P imaging on human maxillary left second molar.
A B
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The dentin HA and the enamel HA have different crystallinity, the crystallinity of enamel HA 
is much higher than that of dentin HA. Moreover, the HA in enamel is regularly arranged, and 
in dentin the arrangement of HA is different from that of the enamel HA in the same section. 
Figure 2. Schematic demonstration on micro structure of enamel, dentin and the mineral nanoparticlefrom 
human tooth. A. The key-hole shape structures are the rods (black dots) crystals of tightly packed into the 
polymeric sheaths in enamel. B. The less organized patterns in the dentin are the collagen fibrils; crystalline is 
distributed within these structure, the dentinal tubules of about 2µm diameter oriented between the pulp and 
dentin–enamel junction. C. The schematic demonstration of signal 31P crystal from human tooth.
6.3. zte and swift 31P Mr images
In the 1H MR image of a maxillary right second molar, the dentinal and pulpal tissues are clearly 
separated: the pulpal tissues showed much higher signal intensity compared to the dentin. In 
contrast, the 31P MR image showed a void for the pulpal tissue due to a much lower phosphate 
content (mainly phospholipids in nerve, vessels, etc.), and dentin was visible as a hyperintense 
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region (Fig. 3 A). In the 1H MR images of a mandibular right first premolar, the buccal pit lesions 
and distal lingual lesions in the crown are clearly seen because of the residual water in these 
lesions (Fig. 3 B top). Instead, the 31P MR image identified mineral breakdown in this area (Fig. 3 
B bottom). For the maxillary left canine, a restoration at the mesial/lingual surface was clearly 
seen on the 1H MR image (Fig. 3 C top). This restoration generated an artifact in this image due to 
the metal content in the material (Fig. 3 C top. dashed curves in yellows). In contrast, the 31P MR 
image better represented the structure of canine by residual mineral content (Fig. 3 C bottom). 
6.4. comparison in snr efficiency between zte and swift
A complete comparison between ZTE and SWIFT is beyond the scope of this paper, here 
we simply compare their SNR efficiency. At “Ernst condition” for small flip angles and fast 
repetitions, an approximation for signal level will be:
Because the noise contribution depend on T
R
 also as , the efficiency (S/N in same total 
acquisition time) of the ZTE and SWIFT sequences at these conditions are not depend on T
R
.
So, we will consider same N- number of acquired points:
ZTE: Signal ~ N, noise ~ 
Figure 3.1H (top) and 31P MR images (bottom) of human maxillary second molar (A), mandibular right first premolar 
(B) and mandibular left canine (C). The premolar contained a defect filled with water, and is pointed with a red 
arrow; the left canine contained repaired defects that are pointed with a red arrow. The observed artifact was 
highlighted by the yellow dashed curves.
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SNR
ZTE
 ~
SWIFT: N
0
- number of samples after pulse, N
p
- number of samples during pulse, N- total 
number of used samples, Only half of samples acquired during pulse are used:
N=N
0
+N
p
/2
Relationships with d
rf
:
Signal~ , d
rec
=1- d
c 
- t
r
b
w
, where t
r
- “dead time” 
Noise ~ 
SNR
SWIFT
 ~
In current gapped SWIFT case, with d
rf
=1, SWIFT
SNR
/ZTE
SNR
~
The comparison between SWIFT and ZTE in SNR is also shown in Figure 4.
Figure 4. Relative SNR of ZTE and SWIFT, as a function of d
rf
. d
rf  
is the rf fraction, values are from 0.2 till 1. d
rec 
is the 
receiver duty cycle, the plotted green curve is for receiver duty cycle equals to 0.5, purple curve is duty cycle in 
0.25. In this study, the values are: 0.5 for d
rec
 and 1 for d
rf
. Therefore, theoretically the ZTE
SNR
/SWIFT
SNR
≈1.4. 
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Figure 5. Pulse sequence used for the measurement of the NOE enhancement of enamel and dentin. The green 
symbolizes the polarization buildup.
Figure 6 NOE enhancement of enamel and dentin as a function of the saturation time. The buildup was modeled 
with a mono-exponential function of the form A(1-exp(-t/T
bu
)), where T
bu
 is a time constant describing the buildup.
6.5. 1h and 31P solid-state nMr studies
In figure 5, the scheme of pulse sequence is shown which we used to quantify the NOE buildup 
in enamel and dentin. In all the experiments the recycle delay (d1) was 750 seconds. The proton 
offset was chosen to be on the water resonance around 5ppm in all the experiments. τ
sat
 and 
the low power saturation pulse were 1ms long. The saturation pulses were at a field of about 
450Hz (measured on a liquid sample). Saturation conditions where optimized by inspection of 
the proton spectra. The proton saturation was varied from 50-500 second by varying the number 
of pulses n from 25000-250000. The enhancement was quantified by comparing the integrated 
intensity of the phosphor spectrum to spectra acquired with n=0. In figure 6 the NOE build-up 
for enamel and dentin are shown together with an exponential fit of the data. The maximum NOE 
measured for dentin reaches 31% and 14% for enamel at 500 sec saturation.  The NOE experiments 
were done at the same field as the imaging experiments (9.4T) to measure at the same conditions.
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The heteronuclear NOE is a cross relaxation effect. In order to be effective two spins 
need to be close proximity and a motion at the sum or difference of their Larmor frequency is 
required transfer the polarization between the nuclei.  To identify the protons involved we tried 
to saturate the different resonances seen in the proton spectra at 15kHz spinning (fig.7) and 
9.4T.  In the inset of figure 7, we show the NOE enhancement reached. The NOE enhancement 
changes little throughout the different positions. Therefore we cannot conclude which proton 
resonance is involved in the NOE buildup.
What is left then is to identify the 31P resonance enhanced. The 31P spectra of enamel and dentin 
consist of different components. We deconvoluted the spectra using the least components 
needed. The enhancement of the individual components as the function of saturation time is 
shown in the article. The deconvolution of the dentin and enamel spectrum in the components 
is shown in figure 8. The residuals of the deconvolution are shown in the trace below the spectra. 
They do not hold much intensity. The same line parameters were used for all the components at 
all saturation times. No significant differences in the enhancement of the components can be 
seen. Therefore also in the 31P spectra no species involved in the enhancement can be identified.
The cross-polarization (CP) dynamics of enamel and dentin are well known. The CP spectra 
of dentin consist of a crystalline and an amorphous component. Since they overlap the 
dynamics can only be separated in time consuming 2D experiments. Qualitatively we see very 
similar build up curves than described earlier for other amorphous and crystalline apatites. The 
CP spectrum at short and long contact times is compared in figure 9.  
The line shape of dentin observed at long contact times using CP is very similar to the line 
shape observed in the direct and the NOE enhanced 31P spectrum. This observation indicates 
that the phosphor sites enhanced by NOE are also remote from protons. At short contact 
Figure 7. 1H spectrum of heat-treated dentin at 15kHz at a field of 400MHz (9.4T). The arrows indicate the 1H 
frequency used for saturation. The inset shows the NOE enhancement observed in dentin at these positions.
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Figure 8. Deconvolution of the dentin 31P  signal (top) and the enamel 31P signal (bottom). The residuals traces in 
both spectra show that the experimental spectra are well represented by the number of components.
A B
Figure 9. Comparison of the 1H->31P CP spectra of dentin at short and long contact times.
times the 31P spectrum is much broader. It is described to heterogeneous environment in the 
amorphous phase of the apatite. 
The amorphous and crystalline phase in dentin show different buildup behavior. It was 
observed for synthetic amorphous apatites that the amorphous phase polarizes quickly until 
around 2ms before vanishing again. At 10-15ms the signal of the amorphous phase vanished. 
The crystalline phase polarizes slowly and reaches its maximum only after about 10ms. In figure 
10 the spectra of dentin and enamel at different contact times is shown. At the top the spectra 
of dentin are shown. The buildup fast, therefore also an amorphous phase is present. The 
polarization decreases after 2ms. Since at 10ms, there is still intensity present, therefore also 
a crystalline phase is present. In contrast, enamel polarizes slowly, doesn’t show prominent 
decrease even after 15 ms. This is in agreement with the fact that it is highly crystalline.
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Figure 10. CP spectra of dentin (top) and enamel  (bottom) as a function of the contact time. The decay of the 
polarization observed at longer contact times for dentin indicates the presence of an amorphous phase. The slow 
buildup in enamel is typical for highly crystalline apatite. All the spectra are acquired using 10kHz spinning and 
are shown for the chemical shift range of -10 to 15ppm.
A
B
The CP parameters are given in the table below:
v
rf
contact time d1 ACQT Number of scans
31P 50 kHz 0.1-15ms 10sec .1ms 4
1H 50 kHz 0.1-15ms
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The use of artificial engineered tissue to support re-growth of tissues in the restoration 
of damaged human organs or part of organs is becoming increasingly important. Three-
dimensional scaffolds are an essential part of most artificial tissues as they provide a structural 
framework upon which host tissue re-growth can proceed. These scaffolds have properties 
that are similar to those of the host tissue that has to be repaired. Non-invasive monitoring of 
engineered tissues during various stages of the whole engineering and repair procedure is very 
important to enable improvements in this process, and is especially important in the evaluation 
of the final in vivo stage during remodeling towards re-growth of host tissue. 
This thesis focuses on the use of MRI as a non-invasive tool to monitor the fate of engineered 
tissue, in particular of the 3D scaffolds. The performance of 3D scaffolds during remodeling is 
critical in achieving a successful recovery for the defected tissues. They should have sufficient 
mechanical strength and good intrinsic biocompatibility; their degradation should be adapted 
to the specific requirement to accomplish proper re-growth of new-tissue. Due to the lack 
of quantitative data by in vivo longitudinal studies, the remodeling of scaffolds such as type 
I collagen scaffold and calcium phosphate cement remains somewhat obscure. Apart from 
knowledge obtained from classical histology and immune-histochemical techniques little is 
known. Non-invasive imaging of scaffolds can greatly assist in the understanding of remodeling 
processes and the effectiveness of scaffolds in regenerating and supporting tissues. An ideal 
imaging tool should be able to provide complete information on composition, structure 
and function of the engineered tissue. Although there is no imaging modality that meets all 
requirements, MRI does provide a versatile, non-invasive way of measuring many morphological 
and physiological parameters associated with changes occurring in engineered tissue. It also 
enables the visualization of both hard and soft tissue simultaneously, and is especially suitable 
for longitudinal in vivo application. 
Chapter 2 reports on the monitoring of iron oxide labeled type I collagen scaffolds using MRI. 
MRI is not comparable with histology in terms of resolution, but it does offer non-destructive 
imaging and enables a long-term tracking of the implanted material. Furthermore, quantitative 
measurements become possible, such as on size and volume. This study indicates that 
longitudinal MRI of USPIO loaded collagen scaffolds can reveal information on their location, 
changes in size even at a challenging anatomical site such as the bladder. This study also 
demonstrated that variable scaffold degradation at different implantation sites, which is likely 
due to a different tissue microenvironment, resulted in distinct cell responses and remodeling. 
Such information is valuable in guiding further development and evaluation process of type I 
collagen scaffolds in soft tissue engineering. 
Chapter 3 and 4 report on new tools for imaging bone and its substitutes in animal models. 
Compared to a conventional MRI acquisition sequence, the zero echo time (ZTE) MRI sequence 
is superior in imaging tissues with extremely short T
2
* relaxation time, such as bone. Potentially, 
these techniques can provide information about the regeneration of bone by substitutes.  In 
comparison to X-ray techniques they have a lower resolution and require longer scan times but 
are much better in providing information on soft tissue. 
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A problem in both X-ray and MR imaging is that substitutes as calcium phosphate cement 
(CPC) and the minerals of natural bone have very similar compositions and hence show very 
little imaging contrast, which hampers de long-term evaluation of the repair process. The 
application of contrast agents such as Gd-DTPA and iron oxide particles in bone substitutes 
could improve this if they have no effect on the proprieties of the material. 
In chapter 3 we describe an investigation of additions of these agents to CPC bone substitutes. 
It appears that indeed MR contrast can be improved in this way and that, at low doses of 
Gd-DTPA, this is possible without changing the properties of the CPC. The calculation of the 
T
2
* relaxation time of bone and bone substitute required some refinement as bound and free 
water in bone have different T
2
* relaxation times. A bi-exponential fit appeared to be more 
appropriate for an accurate calculation of the relaxation times. 
The work described in Chapter 4, demonstrates that the application of gold particles in 
substitutes results in a better X-ray imaging contrast at a lower radiation dose. To enable the 
imaging of bone substitutes both by X-ray computed tomography (CT) and MR, a bi-modal 
contrast agent was developed which consisted of silica bead carrier particles in which both 
gold particles and iron oxide were incorporated.  It was shown that with these particles contrast 
of CPC in bone improved both in CT and MR imaging, thus allowing to obtain different types of 
information. The disappearance of contrast generated by iron particles in MRI and gold particles 
in CT suggested that long-term follow-up of the degradation of bone substitutes is possible, 
by both imaging modalities. The introduction of new imaging techniques, like ZTE-MRI greatly 
facilitated the evaluation of these processes. 
Chapter 5 reports on an approach to simultaneously enhance both imaging and osteogenic 
properties of CPC. With the knowledge obtained in previous studies (chapter 3 and 4), we tested 
a bead-based formulation composed of an iron oxide core, embedded in a mesoporous silica 
matrix on which BMP-2 was immobilized. In vitro testing showed that the loaded theranostic 
agent (TA) beads did not interfere with essential material properties like cement setting. In vivo 
testing in a femoral condyle defect rat model showed that standard non-modified CPC was not 
distinguishable from the surrounding bone tissue. In contrast, the TA-CPC remained detectable 
by MRI up to eight weeks post-implantation. However, in most samples from the MRI/BMP2 
group, contrast was no longer observable after 8 weeks. Such observation indicated that CPC 
remodeling and degradation was accelerated by the activity of BMP-2. The bioactive BMP-2 
was efficiently released, leading to localized and effective bone regeneration. This theranostic 
agent, which aims to improve imaging and therapy combined, is suitable for longitudinal 
studies of material degradation and bone healing process. 
Chapter 6 reports on an approach to image phosphate containing mineral in bone and 
dental tissue. It was demonstrated that 31P ZTE and SWIFT MRI could provide direct imaging of 
minerals in human tooth. 3D Images of the general structure of human teeth were acquired in 
a reasonable scanning time, together with quantitative information of their mineral content. 
Moreover we showed that a heteronuclear (1H-31P) Overhauser Effect (NOE) can enhance 
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the 31P signal of tooth images with regional differences. NMR studies demonstrated that the 
nature of this variation was related to structural differences. To the best of our knowledge this 
is the first study describing a novel method for imaging human teeth with additional structural 
contrast. These approaches might also be attractive in the diagnosis of osteoporosis and other 
bone diseases associated with mineral breakdown. Moreover, by using (NOE enhanced) 31P 
MR imaging, more insight in the contribution of artificial bone substitutes such as synthetic 
calcium phosphate cement (CPC) in the recovery of natural bone might be acquired.
Furthermore, 1H ZTE & SWIFT MRI provide information on the change of water content in 
newly formed bone and bone substitutes over time. Thus the combination of 1H and 31P ZTE/SWIFT 
allows for a comprehensive assessment of bone and bone substitutes in the healing process.
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MRI is a powerful tool in validating tissue-engineering procedures. In this chapter, some 
possible future studies using magnetic resonance imaging (MRI) or magnetic resonance 
spectroscopy (MRS) are addressed.
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1. Mrs in Monitoring tissue engineering
MR spectroscopy (MRS) is a companion technique to MRI focusing mostly on metabolism. The 
resonance frequencies of MR-visible nuclei in metabolites are determined by their chemical 
properties and environment. The resonance signals are visible in a spectrum and correspond to 
constituent metabolites specific profiles. MRS is also suitable to access engineered tissue since it 
enables repeated non-invasive measurements of metabolite content and metabolic dynamics. 
MRS was used to monitor the cell growth and distribution in a bioreactor1. It was also used 
to access bio-artificial meniscal cartilage tissue grown in a bioreactor2. MRS can measure a 
number of parameters that provide further insights into the architecture, concentration, and 
interaction of biopolymers in tissue. The metabolic activity measured by MRS may reveal the 
degradation and the functionality of tissue substitutes and the regeneration of new tissue. 
Moreover, MRS is a quantitative method that can be applied to determine the concentration 
of molecules relative to an internal or external standard. This property may be exploited to 
compare natural and engineered tissues, and to further optimize their design.
The main disadvantage of MRS is its low sensitivity. For example, MRS will only detect 
molecules in cartilage when they are present in a sizable amount. It  does not detect traces of 
molecules in tissues as easy as optical or immunohistochemical assays. The sensitivity of MRS 
can be enhanced by using higher magnetic fields. Chemical exchange saturation transfer (CEST) 
is another way to improve sensitivity of detecting metabolites such as glycosaminoglycan in 
cartilage3. Like in MRI, short T
2
* values are a challange in MRS of engineered hard tissue.  Despite 
its potential, MRS has been hardly applied in monitoring tissue engineering. 
2. 19f and 31P  Mri for tissue engineering
Stem cells containing iron oxide particles are hypointense in MRI after injection, but this method 
has a low specificity and is difficult to quantify. As a result, X-nuclei MRI such as 19F MRI starts to 
draw growing attention. Formulations of contrast agents with 19F have attractive features such 
as a low cytotoxitity and non-presence in natural tissue, which offers a clean background. More 
importantly, the 19F MR signal intensity is directly related to its concentration, which is especially 
useful for cell labeling and cell tracking using MRI4. The encapsulation by using poly (D,L-lactide- 
co-glycolide) (PLGA) further improves its stability, and makes it possible to customize it with 
particle diameter, inclusion of a fluorescent dye, surface charge and bound antibody5. This makes 
it suitable to serve the requirements for cell tracking in tissue engineering. The main problem 
of 19F MR cell tracking is its limited sensitivity: a certain 19F concentration is needed to generate a 
detectable MR signal, therefore a minimum number of labeled cells is required for visualization. 
Different from 19F, 31P is a main nucleus in the human body. Because the major component of 
human mineralized tissue, such as tooth and bone, is hydroxylapatite (HA, Ca
10
(PO
4
)
6
(OH)
2
)6, 31P MR 
imaging gives direct information on mineral content. This may also turn into a clinical application, 
mainly in the diagnosis of osteoporosis. It can also be used in accessing bone substitutes. 
Phosphate containing materials based on hydroxyapatite (HA) or tri-calcium phosphate (TCP) 
may be distinct from surrounding bone tissue in 31P MRI due to the differed T
1
 relaxation times7. 
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Therefore, instead of adding contrast agents such as iodine, barium, and tantalum to increase 
radiopacity of CPCs X-ray, or gadolinium and iron particles to induce MR contrast, such approaches 
my work better for imaging and quantitative assessment at the same time.
Technical challanges still exist in human 31P MR imaging, i.e. customized pulse sequences 
and even customized hardware is required. Problems to overcome in clinical application are 
partial volume effects, field inhomogeneity and long acquisition times. The research on bone 
tissue engineering is expected to benefit from 31P MRI.
3. Mri of dental tissue engineering
The regeneration of dentin, enamel, pulp and integrated tissues is a complicated process. 
Recent advances brought by tissue engineering are expected to change the future of 
dentistry8,9. In particular stem cell therapy in regenerating periodontal tissue10 and scaffold 
implant for dentinal-pulp regeneration seem very promising11. However, as for many other 
tissue engineering approaches, the lack of a proper monitoring technique to access the 
complicated processes remains a big challenge.
X-ray radiography is the gold standard to image human mineralized tissues such as 
bone and tooth. Besides the risk of exposure to a known carcinogen, one drawback is that it 
cannot simultaneously image calcified and non-calcified tissue12, which is highly desired for 
regenerative dentistry13. An alternative imaging modality for dental tissue engineering were 
rarely addressed until the sequences with negligible echo times such as UTE, ZTE and SWIFT, 
that were able to provide images for ultra short T2* components, were introduced14,15,16. These 
new MR techniques expand the possibility of dental MRI: enable the capability of simultaneously 
imaging mineralized and non-mineralized dental tissues, and making longitudinal exams 
without introducing radiation possible.
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Het gebruik van kunstweefsel bij het bevorderen van de hergroei van weefsels om defecte 
organen of onderdelen van organen in het lichaam te repareren wordt steeds belangrijker. 
In dit kunstweefsel worden structurele substraten gebruikt met de eigenschappen van het te 
repareren weefsel. Het  vervolgen van deze substraten in de remodellering tot de hergroei 
van weefsel, vooral in de uiteindelijke in vivo fase, is van groot belang om het hele proces van 
productie van kunstweefsel tot het herstel te kunnen verbeteren. 
Dit proefschrift is gefocusseerd op het gebruik van magnetische resonantie (MR) als niet-
invasieve methode om de hoedanigheid van drie dimensionale groei ondersteunende substraten 
in kunstweefsel te kunnen vervolgen. Momenteel ontbreken veelal kwantitatieve gegevens 
over het groeiproces van nieuw weefsel in vivo en daarom is het ongewis hoe het regeneratie 
proces verloopt. Naast informatie verkregen door klassieke histologie en immuno-chemische 
technieken, is er weinig bekend. Met behulp van niet-invasieve beeldvormende technieken 
kunnen we het (her)modelleringsproces en de regeneratieve en ondersteunende eigenschappen 
van groei modellen beter leren begrijpen. Idealiter zouden deze beeldvormende technieken 
volledige informatie moeten geven over de compositie, structuur en functie van het kunstmatige 
weefsel. Geen enkele modaliteit voldoet aan alle eisen om dit te kunnen, maar MR imaging blijkt 
een veelzijdige, niet-invasieve manier te zijn om veel morfologische en fysiologische parameters 
te meten die van belang zijn om veranderingen in kunstmatig weefsel te kunnen vervolgen. Het 
is uitermate geschikt voor het longitudinaal vervolgen van dit weefsel, aangebracht in levende 
organen (in vivo) en kan zowel harde als weke weefseldelen in beeld te brengen.
Hoofdstuk 2 bespreekt het gebruik van MRI om met ijzeroxide gelabelde type 1 collageen, dat als 
substraat wordt gebruikt in kunstweefsel voor hergroei van weefsel, te vervolgen. Hoewel MRI niet 
de hoge resolutie van histologie biedt, is het wel in staat beelden te maken zonder de structuur 
van het weefsel te vernietigen. Dit maakt het mogelijk om kwantitatieve metingen uit te voeren 
aan geïmplanteerd materiaal en dit materiaal over een lange termijn te vervolgen. In deze studie 
werd met longitudinale MRI van met USPIO geladen collageen informatie worden verzameld over 
locatie, grootte en degradatie van dit materiaal aangebracht in rat. Zelfs voor MR uitdagend gelegen 
organen zoals de blaas bleek dit mogelijk. Deze studie laat ook zien dat degradatie van kunstweefsel 
op verscheidene implantatieplekken, onder invloed van de micro-omgeving, resulteert in 
karakteristieke reacties van het omliggende weefsel bij de hergroei. Deze informatie kan gebruikt 
worden bij de verdere ontwikkeling van type 1 collageen als substraat in groeimodellen.
Hoofdstuk 3 en 4 gaan over proefdier studies waarin nieuwe methoden voor beeldvorming 
van bot, been en substituten, zoals calcium fosfaat verbindingen, worden gepresenteerd. 
Vergeleken met conventionele MRI, is de zero echo time (ZTE) MRI techniek superieur in het 
afbeelden van weefsel met extreem korte transversale relaxatie tijden (T
2
*). In potentie kunnen 
deze technieken informatie geven over de regeneratie van botsubstituten. Vergeleken met 
CT hebben ze een lagere resolutie en vereisen een langere scantijd, maar bieden wel meer 
informatie over weke delen. Zowel voor CT als  MRI is het probleem dat de verschillen tussen 
calcium fosfaat cement als substituut en natuurlijk been te klein zijn om een goed contrast 
te geven, waardoor lange termijn evaluatie van het herstelproces problematisch is. De 
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toepassing van contrastmiddelen zoals Gd-DTPA en ijzeroxide deeltjes in substituten voor 
bot zou verbetering van het contrast kunnen brengen, mits dit niet tot verandering van de 
eigenschappen van het materiaal leiden. 
In hoofdstuk 3 worden toevoegingen van deze contrastmiddelen onderzocht en blijkt dat een 
lage dosis GdDTPA in het botsubstituut calcium fosfaat cement (CPC) geschikt zou kunnen 
zijn voor MR afbeelding. De berekening van de gemeten T
2
* van botsubstituten vereiste enige 
verfijning omdat water in been en vrij water in weefsel verschillende relaxatie tijden hebben. 
Een bi-exponentiële fit leverde een meer accurate bepaling van T2* op.  
Hoofdstuk 4 laat zien dat de toepassing van gouddeeltjes in CT resulteert in hogere absorptie 
met verbeterd contrast bij een lage röntgen dosis. Om botsubstituten zowel met CT als met 
MR zichtbaar te maken werd een bi-modaal contrastmiddel ontwikkeld bestaande uit deeltjes 
die zowel goud als ijzeroxide bevatten. Er werd aangetoond dat met deze deeltjes het contrast 
van CPC in bot verbeterde in MRI en CT. In een kwantitatieve longitudinale studie bleek het 
contrast tussen botsubstituten en natuurlijk been te verdwijnen, wat suggereert dat lange 
termijn vervolging van de degradatie van botsubstituten mogelijk is.  De introductie van nieuwe 
beeldvormende technieken, zoals ZTE MRI, faciliteren de evaluatie van dit proces.
Hoofdstuk 5 beschrijft een methode om gelijktijdig zowel het contrast in de MRI als de 
osteogene eigenschappen van CPC te verbeteren. Met de kennis verkregen uit het werk 
beschreven in hoofdstuk 3 en 4 hebben we een op bolletjes gebaseerde formule getest die 
bestond uit een ijzeroxide kern, gevat in een meso-poreuze silica matrix, waarop BMP-2 was 
geïmmobiliseerd. In vitro testen lieten zien dat dit theranostisch middel geen effect had op 
de essentiële eigenschappen van het materiaal zoals de vorming van het cement. In vivo MRI 
metingen aan een bot defect in de rat laten zien dat de standaard CPC als reparatiemiddel niet 
onderscheiden kan worden van gewoon bot, maar dat CPC met het nieuwe theranostische 
middel wel goed zichtbaar is en wel tot 8 weken postimplantatie. In de meeste samples van 
de MRI/BMP2 group verdween het contrast pas na 8 weken. Dit wijst erop dat de activiteit van 
het BMP-2 de remodeling en degradatie versneld. Dus het ontwikkelde theranostische middel 
is geschikt voor longitudinale studies waarin een verbeterde heling en MR imaging van het 
gerepareerde bot gecombineerd kan worden.
In hoofdstuk 6 worden beeldvormende technieken van fosfaathoudende mineralen in bot- 
en tandweefsel besproken. In dit hoofdstuk wordt aangetoond dat  het mogelijk is om fosfor 
bevattende verbindingen (mineralen) in menselijke tanden direct zichtbaar te maken met 31P 
(fosfor) ZTE en SWIFT MR imaging. 3D beelden van  de generieke structuur van de humane 
tand en kwantitatieve informatie over de mineraalinhoud konden worden verkregen binnen 
redelijke scan tijden. Daarbij werd ook aangetoond dat met het heteronucleair (1H-31P) 
Overhauser Effect (NOE) het 31P signaal van tandweefsel verbetert kan worden en dat er NOE 
afhankelijke regionale verschillen in signaalintensiteit optreden. Met behulp van vaste stof 
NMR studies werd aangetoond dat de aard van deze variaties is gerelateerd aan structurele 
verschillen. Voor zover ons bekend is dit de eerste studie die technieken beschrijft voor 
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beeldvorming van humane tanden met dit extra structureel contrast. Deze technieken kunnen 
ook mogelijkheden bieden voor de diagnose van osteoporose en andere met mineraalafbraak 
geassocieerde botziektes. Bovendien biedt (NOE) 31P MRI beeldvorming mogelijk ook inzicht in 
de bijdrage van kunstmatige botweefselsubstituten, zoals synthetisch calcium fosfaat cement, 
aan het herstel van natuurlijk botweefsel.
Met 1H ZTE en SWIFT MRI kan ook longitudinale informatie over de water inhoud in (nieuw 
gevormd) botweefsel en botweefselsubstituten vergaard worden. De combinatie van 1H and 
31P ZTE/SWIFT, geeft daarom uitgebreide mogelijkheden om botweefsel en zijn substituten te 
evalueren gedurende het genezingsproces bij het herstel van een defect.
139

acknowledgeMents

&A
C
K
N
O
W
LED
G
EM
EN
TS
The successful completion of this manuscript was not possible without the inspiration and 
support of a number of wonderful individuals — my thanks and appreciation to all of them for 
being part of this journey. 
Foremost, I would like to express my deepest gratitude to my supervisor and promoter, 
Prof. Dr. Arend Heerschap, for his continuous support of my PhD study and research, for his 
patience, motivation, enthusiasm, and immense knowledge. During my PhD, I have been given 
great freedom to pursue independent work. His guidance was always there when it’s needed, 
especially towards the completion of this thesis. I could not have imagined having better 
supervisor for my PhD study. 
I would also express my sincere gratitude to my co-promotor Dr. Egbert Oosterwijk, for his 
brilliant idea in initiating the amazing MultiTERM project, for his valuable input for my research 
and publications. Without his enthusiasm, encouragement, constant support, and most 
important, his continuous optimism, this thesis would hardly have been completed. 
Besides my advisors, I would like to thank my mentor, Prof. dr. Otto Boerman. He has made 
available his support in a number of ways, especially in the training, lectures and educational 
courses during my PhD.
I would also like to extend my appreciation to Prof. dr. P. Buma, Prof. dr. W.F.J. Feitz, Prof.dr. P.R. 
Luijten for having accepted to be my manuscript committee, for judging my thesis on scientific 
value, for their encouragement and insightful comments.
The best and worst moments of this journey has been shared with many people. It has been 
a great pleasure to spend several years in Radiology and Urology department, in Radboud 
University Medical Center Nijmegen.
A special thanks to Dr. Tom Scheenen for his insightful question and very helpful advises, and to 
Mark van Uden, Sjaak van Asten, Andor Veltien from Radiology Biomedical MR group, for their 
strong support and guidance. Especially to Andor, who spent lots of time helping me out from 
many difficult projects. 
My working days will not be that pleasant without my wonderful colleagues, thank you 
Patricia, Alan, Thiele, Hetty, Kim, Valerio, Mariam, Barbara, Edwin, Marnix, Isabelle, Houshang, 
Devashish, Edwin, Fernando, Bob, Bart (van de Bank), Vincent, Fritz, Bart (Philips), Eline, Marc, 
Evita, Anne, Martijn, Linda, Nassim, Tom, Tao, Andreas, Maarten, Kristian, Marcel.  Each of you 
contributes in a special way, thank you for all the good time together!
I want to express my appreciation to Prof. Dr. Jack Schalken and my colleagues from Urology 
department, especially to Dr. Paul Geutjes, Dorien, Kees, and Bronte, for the help they have been 
given with the histology analysis presented in this thesis and with other aspects of my research. 
I would like to thank our wonderful project manager, Dr. Nicoline Geverink, who gave me many 
valuable suggestions. I would also like to thank all the MultiTERM partners, collaborators and 
fellows. I really appreciate the great collaborations, and the inspiring meetings together.
143
&
A
C
K
N
O
W
LED
G
EM
EN
TS
I also would like to acknowledge Prof. dr. J.A. Jansen, Dr. X.Frank Walboomers from biomaterial 
department, for their suggestions and guidance in the bone tissue engineering, scientific writing 
and with other aspects of my research. And special thanks to Manuela: we spent hours and hours 
in the lab, and eventually published 3 papers together. It’s always a great pleasure to work with you!
I truly appreciate my collaboration with Prof. dr. Jöns Hilborn, Dr. Dmitri Ossipov, Xia Yang from 
University Uppsala. I’m obliged for their long-term support and their persistence to bring our 
work out.
I also would like to acknowledge Prof. dr. Michael Garwood and Dr. Djaudat Idiyatullin from 
center for magnetic resonance research (CMRR, University of Minnesota), for offering me 
opportunities to work in their group and leading me working on an very exciting project. 
I want to express my gratitude to Prof. dr. Arno Kentgens and Ole Brauckmann from Solid State 
NMR group, in Radboud University Nijmegen, for their insightful suggestions, expert advice 
and excellent support.
Without the contribution of the people from the central Animal Laboratory (CDL) and the 
Preclinical Imaging Centre (Prime), many works in this thesis would never happen. I would like 
to show my gratitude to Bianca, Henk, Kitty and Nicole, for their excellent technical assistance.
亲爱的爸爸,妈妈:感谢你们对我的养育之恩，和你们一直以来给予我的理解、鼓励和
支持，这本书也是献给你们的。
Finally, to the love of my life, Ping. Thank you for the love, support and courage from you. 
Without you, this beautiful journey would not even start.
144


PuBlication list

&PU
BLIC
A
TIO
N
 LIST
Published 
1. Zero Echo Time Magnetic Resonance Imaging of Contrast-Agent-Enhanced Calcium 
Phosphate Bone Defect Fillers
 Yi Sun*, Manuela Ventura*, Egbert Oosterwijk, John A. Jansen, X. Frank Walboomers, Arend 
Heerschap. Tissue Engineering Part C: Methods. April 2013,19(4): 281-287. .*Equal contribution
2. In vivo MR imaging of type I collagen scaffold for an improved visualization in rat: bladder 
and subcutaneous implant
 Yi  Sun, Paul Geutjes, Egbert Oosterwijk, Arend Heerschap. Accepted for Tissue 
Engineering Part C: Methods. In press.
3. Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging
 Yi Sun*, Manuela Ventura*, Viorel Rusu, Peter Lavermam, Paul Borm, Arend Heerschap, 
Egbert  Oosterwijk , Otto C. Boerman, John J. Jansen, Walboomers X. Walboomers. Tissue 
Engineering Part C: Methods. Jun 2013,19(6): 405-16.*Equal contribution.
4. A Theranostic Agent to Enhance Osteogenic and Magnetic Resonance Imaging Properties 
of Calcium Phosphate Cements
 Manuela Ventura, Yi  Sun, Zeinab Tahmasebi Birgani, Sjef Cremers, Paul Borm, Arend 
Heerschap, Peter van der Kraan, John A. Jansen, X. Frank Walboomers. Biomaterials. 
Volume 35, Issue 7, February 2014, Pages 2227–2233.
5. Injectable hyaluronic acid hydrogel for 19F magnetic resonance imaging
 Xia Yang, Yi Sun, Jöns Hilborn, Arend Heerschap, Dmitri Ossipov. Accepted for 
Carbohydrate Polymers. 
6. Injectable in situ forming hybrid iron oxide-hyaluronic acid hydrogel for magnetic 
resonance imaging and drug delivery 
 Yu Zhang, Yi Sun, Xia Yang, Jöns Hilborn, Arend Heerschap, Dmitri Ossipov. Accepted for 
Macromolecular Bioscience 
submitted or ready for submission 
7. Nuclear Overhauser Effect 31P MRI of human tooth with a novel structural contrast. 
 Yi Sun, Ole Brauckmann, Donald R. Nixdorf, Arno Kentgens, Michael Garwood, Djaudat 
Idiyatullin, Arend Heerschap. 
8. The Pre-vascularized Hybrid Scaffolds for Urogenital Tissue Engineering Hybrid scaffolds 
Weilun Sun, Yi Sun, Agnes, Klar, E.Rechimann, A. Heerschap, E. Oosterwijk. 
9. Future Bladder Reconstructions: a spherical hollow collagen bladder construct could be 
an option!
 Henk R. Hoogenkamp, Michiel W. Pot, Dorien Tiemessen, Yi Sun, Egbert Oosterwijk, 
Wout F. Feitz, Willeke F. Daamen  and Toin H. van Kuppevelt.
149

curriculuM vitae

&C
U
RRIC
U
LU
M
 V
ITA
E
Yi Sun was born on 15th of May 1984 in Anhui.  He received his bachelor degree in Biophysics 
at Nankai University, Tianjin, China. At 2006, he started his study in Biomedical Engineering, 
in University Claude Bernard Lyon, France. At 2009, he finished his mater thesis in Diagnostic 
radiology department of University hospital Freiburg.
Since March 2010, he has been employed as a PhD candidate in the department of Urology 
and Radiology, at Radboud University Medical Center Nijmegen, under the supervision of 
Prof. Arend Heerschap and Dr. Egbert Oosterwijk. His PhD project was part of a prestigious 
Marie Curie Initial Training Network (ITN) as funded by the European Union. His project mainly 
focuses on using Magnetic resonance imaging (MRI) in monitoring engineered tissues and 
biomaterials. The results of his work are described in this thesis and are presented as separate 
publications in scientific journals.
153

